Allowable Total Error Table

Total Allowable Error Table


Contact Us


11-Deoxycortisol
Analyte Fluid Method Limit Source
11-Deoxycortisol 30 nmol/L, 15% 7 RCPA
11-Desoxycortisol
Analyte Fluid Method Limit Source
11-Desoxycortisol S- 27.1% 5 BV
17-Hydroxyprogesterone
Analyte Fluid Method Limit Source
17-Hydroxyprogesterone S- 30.2% 5 BV
17-Hydroxyprogesterone 3 nmol/L, 20% 7 RCPA
5'-Hidroxiindolacetate, concentration, 2
Analyte Fluid Method Limit Source
5'-Hidroxiindolacetate, concentration, 2 U- 26.5% 5 BV
5'Nucleotidase
Analyte Fluid Method Limit Source
5'Nucleotidase S- 26.8% 5 BV
5HIAA
Analyte Fluid Method Limit Source
5HIAA 20 umol/day, 20% 7 RCPA
a-Amylase
Analyte Fluid Method Limit Source
a-Amylase S- 15.7% 5 BV
a-Amylase (pancreatic)
Analyte Fluid Method Limit Source
a-Amylase (pancreatic) S- 17.7% 5 BV
a-Amylase concentration, random
Analyte Fluid Method Limit Source
a-Amylase concentration, random U- 103.7% 5 BV
a-Tocopherol
Analyte Fluid Method Limit Source
a-Tocopherol S- 16.2% 5 BV
A/C Ratio
Analyte Fluid Method Limit Source
A/C Ratio 2.5 SD 2 WLSH
a1-Acid Glycoprotein
Analyte Fluid Method Limit Source
a1-Acid Glycoprotein S- 16.2% 5 BV
a1-Antichymotrypsin
Analyte Fluid Method Limit Source
a1-Antichymotrypsin S- 16.8% 5 BV
a1-Antitrypsin
Analyte Fluid Method Limit Source
a1-Antitrypsin S- 9.2% 5 BV
a1-Globulins
Analyte Fluid Method Limit Source
a1-Globulins S- 15.7% 5 BV
a1-Microglobulin, concentration, first m
Analyte Fluid Method Limit Source
a1-Microglobulin, concentration, first m U- 43.9% 5 BV
a2-Globulins
Analyte Fluid Method Limit Source
a2-Globulins S- 12.6% 5 BV
a2-Macroglobulin
Analyte Fluid Method Limit Source
a2-Macroglobulin S- 7.6% 5 BV
a2-Microglobulin output, overnight
Analyte Fluid Method Limit Source
a2-Microglobulin output, overnight U- 34.7% 5 BV
Acetaminophen
Analyte Fluid Method Limit Source
Acetaminophen 25% 2 WLSH
Acetaminophen +/- 15% 3 NYS
Acetaminophen Abbott AxSym 3 SD 4 CAP
Acetaminophen 2.5 mg/mL or 25% 6 AAB
Acetaminophen 20% 8 CFX
Acetone
Analyte Fluid Method Limit Source
Acetone 25% 2 WLSH
Acid Phos(Pros)
Analyte Fluid Method Limit Source
Acid Phos(Pros) 1.5 U/L & ug/L, 15% 7 RCPA
Acid Phos(Total)
Analyte Fluid Method Limit Source
Acid Phos(Total) 1.5 U/L & ug/L, 15% 7 RCPA
Acid phosphatase
Analyte Fluid Method Limit Source
Acid phosphatase S- 10.3% 5 BV
Acid phosphatase tartrate resistent
Analyte Fluid Method Limit Source
Acid phosphatase tartrate resistent S- 13.2% 5 BV
ACTH
Analyte Fluid Method Limit Source
ACTH 2.0 pmol/L, 10% 7 RCPA
Activated Clotting Time
Analyte Fluid Method Limit Source
Activated Clotting Time 20% 6 AAB
Activated Clotting Time (ACT)
Analyte Fluid Method Limit Source
Activated Clotting Time (ACT) 2 SD 2 WLSH
Activated Partial Thrombo Time
Analyte Fluid Method Limit Source
Activated Partial Thrombo Time 15% 6 AAB
Activated partial thromboplastine time
Analyte Fluid Method Limit Source
Activated partial thromboplastine time P- 4.5% 5 BV
Active Renin
Analyte Fluid Method Limit Source
Active Renin 1.0 uU/mL, 25% 7 RCPA
Adenosine deaminase
Analyte Fluid Method Limit Source
Adenosine deaminase S- 16.7% 5 BV
Adrenaline
Analyte Fluid Method Limit Source
Adrenaline 50 nmol/day, 33% 7 RCPA
AFP
Analyte Fluid Method Limit Source
AFP Centaur 3 SD 4 CAP
AFP 5 kIU/L, 20% 7 RCPA
AFP (Amniotic Fluid)
Analyte Fluid Method Limit Source
AFP (Amniotic Fluid) +/- 3 SD 3 NYS
AFP (Maternal Sera)
Analyte Fluid Method Limit Source
AFP (Maternal Sera) +/- 3 SD 3 NYS
AFP, Amniotic Fluid
Analyte Fluid Method Limit Source
AFP, Amniotic Fluid Centaur 3 SD 4 CAP
AFP-Tumor (Chiron)
Analyte Fluid Method Limit Source
AFP-Tumor (Chiron) Centaur 3 SD 4 CAP
AFPTM
Analyte Fluid Method Limit Source
AFPTM +/- 3 SD 3 NYS
Alanine aminotransferase
Analyte Fluid Method Limit Source
Alanine aminotransferase S- 32.1% 5 BV
Alanine Aminotransferase
Analyte Fluid Method Limit Source
Alanine Aminotransferase 20% 6 AAB
Alanine Aminotransferase 35% 8 CFX
Alanine aminotransferase (ALT, SGPT)
Analyte Fluid Method Limit Source
Alanine aminotransferase (ALT, SGPT) +/- 20% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Albumin
Analyte Fluid Method Limit Source
Albumin +/- 10% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Albumin AU640 10% 4 CAP
Albumin S- 3.9% 5 BV
Albumin 2.0 g/L, 10% 7 RCPA
Albumin 10% 8 CFX
Albumin, concentration, first morning
Analyte Fluid Method Limit Source
Albumin, concentration, first morning U- 46.1% 5 BV
Albumin-Blood
Analyte Fluid Method Limit Source
Albumin-Blood BNII 20% 4 CAP
Albumin-CSF
Analyte Fluid Method Limit Source
Albumin-CSF BNII 20% 4 CAP
Albumin-CSF CSF 0.10 g/L, 10% 7 RCPA
Albumin-Urine
Analyte Fluid Method Limit Source
Albumin-Urine U- 0.1 g/L, 10% 7 RCPA
Alcohol
Analyte Fluid Method Limit Source
Alcohol 2.2 mmol/L, 10% 7 RCPA
Alcohol (Ethanol), Urine
Analyte Fluid Method Limit Source
Alcohol (Ethanol), Urine Pos/Neg 2 WLSH
Alcohol, blood
Analyte Fluid Method Limit Source
Alcohol, blood +/- 25% 1 CLIA, 2 WLSH, 6 AAB
Alcohol, Serum
Analyte Fluid Method Limit Source
Alcohol, Serum 25% 6 AAB
Alcohol,blood
Analyte Fluid Method Limit Source
Alcohol,blood +/- 10% 3 NYS
Aldosterone
Analyte Fluid Method Limit Source
Aldosterone S- 36.7% 5 BV
Aldosterone 75.0 pmol/L, 15% 7 RCPA
Aldosterone, concentration
Analyte Fluid Method Limit Source
Aldosterone, concentration U- 39.6% 5 BV
Alk Phos
Analyte Fluid Method Limit Source
Alk Phos AU640 30% 4 CAP
Alkaline Phosphatase
Analyte Fluid Method Limit Source
Alkaline Phosphatase 30% 6 AAB
Alkaline Phosphatase 15 U/L, 15% 7 RCPA
Alkaline Phosphatase 30% 8 CFX
Alkaline phosphatase
Analyte Fluid Method Limit Source
Alkaline phosphatase +/- 30% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Alkaline phosphatase S- 11.7% 5 BV
Alkaline phosphatase, bone isoform
Analyte Fluid Method Limit Source
Alkaline phosphatase, bone isoform S- 14.5% 5 BV
Alpha 1 Antitrypsin
Analyte Fluid Method Limit Source
Alpha 1 Antitrypsin BNII 3 SD 4 CAP
Alpha fetoprotein (Prenatal screen)
Analyte Fluid Method Limit Source
Alpha fetoprotein (Prenatal screen) 3 SD 2 WLSH
Alpha-1 antitrypsin
Analyte Fluid Method Limit Source
Alpha-1 antitrypsin +/- 3 SD 1 CLIA, 3 NYS, 6 AAB
Alpha-1-Antitrypsin
Analyte Fluid Method Limit Source
Alpha-1-Antitrypsin 3SD 6 AAB
Alpha-fetoprotein
Analyte Fluid Method Limit Source
Alpha-fetoprotein +/- 3 SD 1 CLIA, 2 WLSH
Alpha-fetoprotein 5 kIU/L, 20% 7 RCPA
ALT
Analyte Fluid Method Limit Source
ALT AU640 20% 4 CAP
ALT 8 U/L, 15% 7 RCPA
Amikacin
Analyte Fluid Method Limit Source
Amikacin 25% 2 WLSH
Amikacin 2.0 mg/L, 10% 7 RCPA
Amikacin 15% 8 CFX
Amiodarone
Analyte Fluid Method Limit Source
Amiodarone 0.2 umol/L, 10% 7 RCPA
Amitriptyline
Analyte Fluid Method Limit Source
Amitriptyline 10 umol/L, 10% 7 RCPA
Amitriptyline 15% 8 CFX
Ammonia
Analyte Fluid Method Limit Source
Ammonia 2.5 SD 2 WLSH
Ammonia AU640 not evaluated 4 CAP
Ammonia 3 umol/L, 10% 7 RCPA
Ammonia, output
Analyte Fluid Method Limit Source
Ammonia, output U- 29.6% 5 BV
Ammonia, Serum
Analyte Fluid Method Limit Source
Ammonia, Serum 10 umol/L or 5% 6 AAB
Amphetamine
Analyte Fluid Method Limit Source
Amphetamine Abbott AxSym 80% consensus 4 CAP
Amphetamines
Analyte Fluid Method Limit Source
Amphetamines Pos/Neg 2 WLSH
Amphetamines 20% or 2 SD 3 NYS
Amphetamines, qualitative
Analyte Fluid Method Limit Source
Amphetamines, qualitative Presence or Absence 3 NYS
Amylase
Analyte Fluid Method Limit Source
Amylase +/- 30% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Amylase AU640 30% 4 CAP
Amylase 15 U/L, 15% 7 RCPA
Amylase 20% 8 CFX
Amylase -urine
Analyte Fluid Method Limit Source
Amylase -urine U- 30% 2 WLSH
Amylase, urine
Analyte Fluid Method Limit Source
Amylase, urine U- AU640 3 SD 4 CAP
Androstendione
Analyte Fluid Method Limit Source
Androstendione S- 22.6% 5 BV
Androstenedione
Analyte Fluid Method Limit Source
Androstenedione 2.0 nmol/L 7 RCPA
Angiotensin converting enzyme
Analyte Fluid Method Limit Source
Angiotensin converting enzyme P- 17.9% 5 BV
Anti-CMV
Analyte Fluid Method Limit Source
Anti-CMV Positive or Negative 3 NYS
Anti-Human Immunodeficiency virus
Analyte Fluid Method Limit Source
Anti-Human Immunodeficiency virus Reaction or nonreactive 1 CLIA
Antinuclear antibody
Analyte Fluid Method Limit Source
Antinuclear antibody Target value +/- 2 dilution or (pos. or neg.) 1 CLIA, 3 NYS
Antistreptolysin O
Analyte Fluid Method Limit Source
Antistreptolysin O Target value +/- 2 dilution or (pos. or neg.) 1 CLIA, 3 NYS
Antithrombin III
Analyte Fluid Method Limit Source
Antithrombin III P- 8.3% 5 BV
Apolipoprotein A1
Analyte Fluid Method Limit Source
Apolipoprotein A1 BNII 3 SD 4 CAP
Apolipoprotein A1 S- 9.1% 5 BV
Apolipoprotein A1 25 mg/dL or 30% 6 AAB
Apolipoprotein A1 0.2 g/L, 10% 7 RCPA
Apolipoprotein AI
Analyte Fluid Method Limit Source
Apolipoprotein AI 10% 8 CFX
Apolipoprotein b
Analyte Fluid Method Limit Source
Apolipoprotein b BNII 3 SD 4 CAP
Apolipoprotein B
Analyte Fluid Method Limit Source
Apolipoprotein B S- 11.6% 5 BV
Apolipoprotein B 20 mg/dL or 25% 6 AAB
Apolipoprotein B 0.2 g/L, 10% 7 RCPA
Apolipoprotein B 12% 8 CFX
Apolipoprotein B100
Analyte Fluid Method Limit Source
Apolipoprotein B100 BNII not evaluated 4 CAP
Ascorbic Acid
Analyte Fluid Method Limit Source
Ascorbic Acid S- 29.9% 5 BV
Aso-Antistreptolysin
Analyte Fluid Method Limit Source
Aso-Antistreptolysin BNII 2 SD 4 CAP
Aspartate aminotransferase
Analyte Fluid Method Limit Source
Aspartate aminotransferase S- 15.2% 5 BV
Aspartate Aminotransferase
Analyte Fluid Method Limit Source
Aspartate Aminotransferase 20% 6 AAB
Aspartate Aminotransferase 20% 8 CFX
Aspartate aminotransferase (AST, SGOT)
Analyte Fluid Method Limit Source
Aspartate aminotransferase (AST, SGOT) +/- 20% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
AST
Analyte Fluid Method Limit Source
AST AU640 20% 4 CAP
AST 8 U/L, 15% 7 RCPA
Automated Differential
Analyte Fluid Method Limit Source
Automated Differential 3SD 6 AAB
b-Carotene
Analyte Fluid Method Limit Source
b-Carotene S- 43% 5 BV
b-Globulins
Analyte Fluid Method Limit Source
b-Globulins S- 11.7% 5 BV
b2-Microglobulin
Analyte Fluid Method Limit Source
b2-Microglobulin S- 9% 5 BV
Barbituates
Analyte Fluid Method Limit Source
Barbituates 20% or 2 SD 3 NYS
Barbiturate
Analyte Fluid Method Limit Source
Barbiturate Abbott AxSym 80% consensus 4 CAP
Barbiturates
Analyte Fluid Method Limit Source
Barbiturates Pos/Neg 2 WLSH
Basophile, count
Analyte Fluid Method Limit Source
Basophile, count S- 38.5% 5 BV
Benzodiazepine
Analyte Fluid Method Limit Source
Benzodiazepine 20% or 2 SD 3 NYS
Benzodiazepine Abbott AxSym 80% consensus 4 CAP
Benzodiazepines
Analyte Fluid Method Limit Source
Benzodiazepines Pos/Neg 2 WLSH
Benzoylecgonine
Analyte Fluid Method Limit Source
Benzoylecgonine 20% or 2 SD 3 NYS
Beta 2 microglobulin
Analyte Fluid Method Limit Source
Beta 2 microglobulin 0.06 mg/L or 30% 6 AAB
Beta Carotene
Analyte Fluid Method Limit Source
Beta Carotene 0.2 umol/L, 10% 7 RCPA
Beta-2 Microglobulin
Analyte Fluid Method Limit Source
Beta-2 Microglobulin 0.2 mg/L, 10% 7 RCPA
Beta-Hydroxybutyric Acid
Analyte Fluid Method Limit Source
Beta-Hydroxybutyric Acid 2 SD 8 CFX
Bicarbonate
Analyte Fluid Method Limit Source
Bicarbonate 2.0 mmol/L, 10% 7 RCPA
Bicarbonate (Total CO2)
Analyte Fluid Method Limit Source
Bicarbonate (Total CO2) 4 mEq/L or 20% 6 AAB
Bilirubin - Direct
Analyte Fluid Method Limit Source
Bilirubin - Direct 50% 8 CFX
Bilirubin - Neonatal
Analyte Fluid Method Limit Source
Bilirubin - Neonatal 31% 8 CFX
Bilirubin - Total
Analyte Fluid Method Limit Source
Bilirubin - Total 5 umol/L, 10% 7 RCPA
Bilirubin - Total 31% 8 CFX
Bilirubin conjugated
Analyte Fluid Method Limit Source
Bilirubin conjugated S- 44.5% 5 BV
Bilirubin Conjugated
Analyte Fluid Method Limit Source
Bilirubin Conjugated 10 umol/L, 20% 7 RCPA
Bilirubin total
Analyte Fluid Method Limit Source
Bilirubin total S- 31.1% 5 BV
Bilirubin, Direct
Analyte Fluid Method Limit Source
Bilirubin, Direct AU640 20% or 0.4 mg/dL (greater) 4 CAP
Bilirubin, Total
Analyte Fluid Method Limit Source
Bilirubin, Total AU640 20% or 0.4 mg/dL (greater) 4 CAP
Bilirubin, Total 0.4 mg/dL or 20% 6 AAB
Bilirubin, total
Analyte Fluid Method Limit Source
Bilirubin, total +/- 0.4 mg/dL or +/- 20% (greater) 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Bilirubin, Urine (qual)
Analyte Fluid Method Limit Source
Bilirubin, Urine (qual) 80% Agreement 3 NYS
Bilirubin,direct
Analyte Fluid Method Limit Source
Bilirubin,direct 0.4 mg/dL or 20% 2 WLSH
Bilirubin,Neonatal
Analyte Fluid Method Limit Source
Bilirubin,Neonatal 0.4 mg/dL or 20% 2 WLSH
Blood gas p02
Analyte Fluid Method Limit Source
Blood gas p02 +/- 3 SD 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Blood gas pCO2
Analyte Fluid Method Limit Source
Blood gas pCO2 +/- 5 mm Hg or +/- 8% (greater) 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Blood gas pH
Analyte Fluid Method Limit Source
Blood gas pH +/- 0.04 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Blood lead
Analyte Fluid Method Limit Source
Blood lead +/- 10% or +/- 4 mcg/dL (greater) 1 CLIA, 2 WLSH
BNP
Analyte Fluid Method Limit Source
BNP 2.0 SD 2 WLSH
BNP Centaur not evaluated 4 CAP
BNP 5.0 pg/mL or 20% 6 AAB
BPb:
Analyte Fluid Method Limit Source
BPb: +/-4 µg/dL (values <40µg/dL) or +/-10% (values >40µg/dL) 3 NYS
Bright CD45-/CD14+
Analyte Fluid Method Limit Source
Bright CD45-/CD14+ 3 SD 2 WLSH
C Peptide
Analyte Fluid Method Limit Source
C Peptide S- 11.7% 5 BV
C Peptide 1.0 nmol/L, 10% 7 RCPA
C-Propeptide type I procollagen
Analyte Fluid Method Limit Source
C-Propeptide type I procollagen S- 11.6% 5 BV
C-Reactive protein
Analyte Fluid Method Limit Source
C-Reactive protein S- 68.3% 5 BV
C-Telopeptide type I procollagen
Analyte Fluid Method Limit Source
C-Telopeptide type I procollagen S- 14.1% 5 BV
C3 Complement
Analyte Fluid Method Limit Source
C3 Complement BNII 3 SD 4 CAP
C3 complement
Analyte Fluid Method Limit Source
C3 complement S- 8.4% 5 BV
C4 Complement
Analyte Fluid Method Limit Source
C4 Complement BNII 3 SD 4 CAP
C4 complement
Analyte Fluid Method Limit Source
C4 complement S- 16% 5 BV
CA 125
Analyte Fluid Method Limit Source
CA 125 2 SD 2 WLSH
CA 125 antigen
Analyte Fluid Method Limit Source
CA 125 antigen S- 38.2% 5 BV
CA 15-3
Analyte Fluid Method Limit Source
CA 15-3 2 SD 2 WLSH
CA 15.3 antigen
Analyte Fluid Method Limit Source
CA 15.3 antigen S- 15.5% 5 BV
CA 19-9
Analyte Fluid Method Limit Source
CA 19-9 2 SD 2 WLSH
CA 19.9 antigen
Analyte Fluid Method Limit Source
CA 19.9 antigen S- 44.3% 5 BV
CA 549 antigen
Analyte Fluid Method Limit Source
CA 549 antigen S- 16.2% 5 BV
CA-125
Analyte Fluid Method Limit Source
CA-125 9 U/mL or 30% 6 AAB
CA125
Analyte Fluid Method Limit Source
CA125 +/- 3 SD 3 NYS
CA125 20 kU/L, 20% 7 RCPA
CA15-3
Analyte Fluid Method Limit Source
CA15-3 +/- 3 SD 3 NYS
CA15-3 3 kU/L, 15% 7 RCPA
CA19-9
Analyte Fluid Method Limit Source
CA19-9 +/- 3 SD 3 NYS
CA19-9 3 kU/L, 15% 7 RCPA
CA27.29
Analyte Fluid Method Limit Source
CA27.29 +/- 3 SD 3 NYS
Caffeine
Analyte Fluid Method Limit Source
Caffeine 15% 8 CFX
Calcitonin
Analyte Fluid Method Limit Source
Calcitonin 2 ng/L, 10% 7 RCPA
Calcium
Analyte Fluid Method Limit Source
Calcium AU640 1 mg/dL 4 CAP
Calcium S- 2.4% 5 BV
Calcium U- 1.0 mg/dL 6 AAB
Calcium 1.0 mg/dL 6 AAB
Calcium 0.10 mmol/L 7 RCPA
Calcium 8% 8 CFX
Calcium - Ionized
Analyte Fluid Method Limit Source
Calcium - Ionized 10% 8 CFX
Calcium - urine
Analyte Fluid Method Limit Source
Calcium - urine U- 1 mg/dL 2 WLSH
Calcium, concentration, 24h
Analyte Fluid Method Limit Source
Calcium, concentration, 24h U- 34.1% 5 BV
Calcium, Ionized
Analyte Fluid Method Limit Source
Calcium, Ionized Radiometer 725 3 SD 4 CAP
Calcium, ionized
Analyte Fluid Method Limit Source
Calcium, ionized U- 2.1% 5 BV
Calcium, output, 24h
Analyte Fluid Method Limit Source
Calcium, output, 24h U- 31% 5 BV
Calcium, total
Analyte Fluid Method Limit Source
Calcium, total +/- 1.0 mg/dL 1 CLIA
Calcium, urine
Analyte Fluid Method Limit Source
Calcium, urine U- AU640 31% 4 CAP
Calcium-Urine
Analyte Fluid Method Limit Source
Calcium-Urine U- 0.20 mmol/L 7 RCPA
Cannabinoid
Analyte Fluid Method Limit Source
Cannabinoid Abbott AxSym 80% consensus 4 CAP
Cannabinoids
Analyte Fluid Method Limit Source
Cannabinoids Pos/Neg 2 WLSH
Carbamazepine
Analyte Fluid Method Limit Source
Carbamazepine +/- 25% 1 CLIA, 2 WLSH, 6 AAB
Carbamazepine +/- 15% 3 NYS
Carbamazepine Abbott AxSym 25% 4 CAP
Carbamazepine 2.0 umol/L, 10% 7 RCPA
Carbamazepine 25% 8 CFX
Carbamazepine, free
Analyte Fluid Method Limit Source
Carbamazepine, free TDX 3 SD 4 CAP
Carbohydrate deficient transferrin
Analyte Fluid Method Limit Source
Carbohydrate deficient transferrin S- 15.7% 5 BV
Carbon Dioxide
Analyte Fluid Method Limit Source
Carbon Dioxide 5.0 mmol/L 2 WLSH
Carboxyhemoglobin
Analyte Fluid Method Limit Source
Carboxyhemoglobin 3 SD 2 WLSH
Carboxyhemoglobin Radiometer 725 3 SD 4 CAP
Carcinoembryonic antigen
Analyte Fluid Method Limit Source
Carcinoembryonic antigen S- 21.8% 5 BV
Carcinoembryonic Antigen
Analyte Fluid Method Limit Source
Carcinoembryonic Antigen 1.2 ng/mL or 30% 6 AAB
CD19+
Analyte Fluid Method Limit Source
CD19+ 3 SD 2 WLSH
CD2+
Analyte Fluid Method Limit Source
CD2+ 3 SD 2 WLSH
CD20+
Analyte Fluid Method Limit Source
CD20+ 3 SD 2 WLSH
CD3+
Analyte Fluid Method Limit Source
CD3+ 3 SD 2 WLSH
CD3+/CD4+
Analyte Fluid Method Limit Source
CD3+/CD4+ 3 SD 2 WLSH
CD3+/CD8+
Analyte Fluid Method Limit Source
CD3+/CD8+ 3 SD 2 WLSH
CD3-/CD16+56+
Analyte Fluid Method Limit Source
CD3-/CD16+56+ 3 SD 2 WLSH
CD4+
Analyte Fluid Method Limit Source
CD4+ 3 SD 2 WLSH
CD5+
Analyte Fluid Method Limit Source
CD5+ 3 SD 2 WLSH
CD8+
Analyte Fluid Method Limit Source
CD8+ 3 SD 2 WLSH
CEA
Analyte Fluid Method Limit Source
CEA 1.2 ng/mL or 30% 2 WLSH
CEA +/- 3 SD 3 NYS
CEA Abbott AxSym 3 SD 4 CAP
CEA 2.0 ug/L, 20% 7 RCPA
Cell identification
Analyte Fluid Method Limit Source
Cell identification 90% or greater consensus on identification 1 CLIA, 3 NYS
Ceruloplasmin
Analyte Fluid Method Limit Source
Ceruloplasmin BNII 3 SD 4 CAP
Ceruloplasmin S- 7.8% 5 BV
Chloride
Analyte Fluid Method Limit Source
Chloride +/- 5% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Chloride Radiometer 725 5% 4 CAP
Chloride AU640 5% 4 CAP
Chloride S- 1.5% 5 BV
Chloride 3.0 mmol/L 7 RCPA
Chloride 5% 8 CFX
Chloride -urine
Analyte Fluid Method Limit Source
Chloride -urine U- 5% 2 WLSH
Chloride, urine
Analyte Fluid Method Limit Source
Chloride, urine U- AU640 3 SD 4 CAP
Chloride-Sweat
Analyte Fluid Method Limit Source
Chloride-Sweat Sweat 2 mmol/L, 10% 7 RCPA
Chloride-Urine
Analyte Fluid Method Limit Source
Chloride-Urine U- 2.0 mmol/L, 10% 7 RCPA
Cholesterol
Analyte Fluid Method Limit Source
Cholesterol AU640 10% 4 CAP
Cholesterol S- 9% 5 BV
Cholesterol 0.50 mmol/L, 5% 7 RCPA
Cholesterol - HDL
Analyte Fluid Method Limit Source
Cholesterol - HDL 11% 8 CFX
Cholesterol - LDL
Analyte Fluid Method Limit Source
Cholesterol - LDL 15% 8 CFX
Cholesterol - Total
Analyte Fluid Method Limit Source
Cholesterol - Total 9% 8 CFX
Cholesterol, high dens. lipoprotein
Analyte Fluid Method Limit Source
Cholesterol, high dens. lipoprotein +/- 30% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Cholesterol, total
Analyte Fluid Method Limit Source
Cholesterol, total +/- 10% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Cholesterol, Total
Analyte Fluid Method Limit Source
Cholesterol, Total 10% 6 AAB
Cholesterol,LDL
Analyte Fluid Method Limit Source
Cholesterol,LDL 30% 2 WLSH
Cholesterol,LDL Non-graded analyte 3 NYS
Cholinesterase
Analyte Fluid Method Limit Source
Cholinesterase S- 8.9% 5 BV
Cholinesterase, catalitic activity
Analyte Fluid Method Limit Source
Cholinesterase, catalitic activity S- 7.4% 5 BV
CK, Total
Analyte Fluid Method Limit Source
CK, Total AU640 30% 4 CAP
Ck-MB
Analyte Fluid Method Limit Source
Ck-MB Centaur 3 SD 4 CAP
CK-MB
Analyte Fluid Method Limit Source
CK-MB 6 U/L & ug/L, 15% 7 RCPA
CK-MB Activity
Analyte Fluid Method Limit Source
CK-MB Activity 40% 8 CFX
CK-MB Mass
Analyte Fluid Method Limit Source
CK-MB Mass 2 SD 8 CFX
CK-MB qualitative
Analyte Fluid Method Limit Source
CK-MB qualitative Pos/Neg 2 WLSH
CK2 Isoenzyme (CKMB)
Analyte Fluid Method Limit Source
CK2 Isoenzyme (CKMB) 3SD 6 AAB
CO2
Analyte Fluid Method Limit Source
CO2 AU640 3 SD 4 CAP
CO2 - Total
Analyte Fluid Method Limit Source
CO2 - Total 20% 8 CFX
CoaguChek Prothrombin Time
Analyte Fluid Method Limit Source
CoaguChek Prothrombin Time 15% 6 AAB
Cocaine Metab
Analyte Fluid Method Limit Source
Cocaine Metab Pos/Neg 2 WLSH
Cocaine-Metabolite
Analyte Fluid Method Limit Source
Cocaine-Metabolite Abbott AxSym 80% consensus 4 CAP
Complement C3
Analyte Fluid Method Limit Source
Complement C3 +/- 3 SD 1 CLIA, 3 NYS, 6 AAB
Complement C4
Analyte Fluid Method Limit Source
Complement C4 +/- 3 SD 1 CLIA, 3 NYS, 6 AAB
Conjugated Bilirubin, Neonatal
Analyte Fluid Method Limit Source
Conjugated Bilirubin, Neonatal 10 umol/L, 20% 7 RCPA
Copper
Analyte Fluid Method Limit Source
Copper S- 7.7% 5 BV
Copper P- 11.8% 5 BV
Cortisol
Analyte Fluid Method Limit Source
Cortisol +/- 25% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Cortisol Centaur 25% 4 CAP
Cortisol S- 29.8% 5 BV
Cortisol 30 nmol/L, 15% 7 RCPA
Cortisol 30% 8 CFX
cPSA
Analyte Fluid Method Limit Source
cPSA +/- 3 SD 3 NYS
Creatine kinase
Analyte Fluid Method Limit Source
Creatine kinase +/- 30% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Creatine kinase S- 30.3% 5 BV
Creatine Kinase
Analyte Fluid Method Limit Source
Creatine Kinase 30% 6 AAB
Creatine Kinase 15 U/L, 15% 7 RCPA
Creatine Kinase 30% 8 CFX
Creatine kinase isoenzymes
Analyte Fluid Method Limit Source
Creatine kinase isoenzymes MB elevated (present or absent) or Target value +/- 3 SD 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Creatine kinase MB, %
Analyte Fluid Method Limit Source
Creatine kinase MB, % S- 16.5% 5 BV
Creatine kinase MB, activity
Analyte Fluid Method Limit Source
Creatine kinase MB, activity S- 24.1% 5 BV
Creatine kinase MB, mass
Analyte Fluid Method Limit Source
Creatine kinase MB, mass S- 31.2% 5 BV
Creatinine
Analyte Fluid Method Limit Source
Creatinine +/- 0.3 mg/dL or +/- 15% (greater) 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Creatinine AU640 15% or 0.3 mg/dL (greater) 4 CAP
Creatinine S- 6.9% 5 BV
Creatinine 0.01 mmol/L, 10% 7 RCPA
Creatinine 25% 8 CFX
Creatinine - quantitative, Urine
Analyte Fluid Method Limit Source
Creatinine - quantitative, Urine 0.3 mg/dL or 17% 2 WLSH
Creatinine - semi quant, Urine
Analyte Fluid Method Limit Source
Creatinine - semi quant, Urine 2 WLSH
Creatinine clearence
Analyte Fluid Method Limit Source
Creatinine clearence Patient- 16% 5 BV
Creatinine, concentration
Analyte Fluid Method Limit Source
Creatinine, concentration U- 28.4% 5 BV
Creatinine, output
Analyte Fluid Method Limit Source
Creatinine, output U- 15.4% 5 BV
Creatinine, urine
Analyte Fluid Method Limit Source
Creatinine, urine U- AU640 17% 4 CAP
Creatinine-Urine
Analyte Fluid Method Limit Source
Creatinine-Urine U- 0.5 mmol/L, 10% 7 RCPA
CRP
Analyte Fluid Method Limit Source
CRP BNII 2 SD 4 CAP
CRP 0.4 mg/dL or 3 SD% 6 AAB
Cryptococcus neoformans Antigen
Analyte Fluid Method Limit Source
Cryptococcus neoformans Antigen Positive or Negative or +/- 2 dilutions 3 NYS
CSF Protein
Analyte Fluid Method Limit Source
CSF Protein AU640 2 SD 4 CAP
Cyclosporine
Analyte Fluid Method Limit Source
Cyclosporine TDX 3 SD 4 CAP
Cystein
Analyte Fluid Method Limit Source
Cystein P- 8.3% 5 BV
D-Dimer
Analyte Fluid Method Limit Source
D-Dimer 30% 6 AAB
d-Dimer (interpretation)
Analyte Fluid Method Limit Source
d-Dimer (interpretation) Pos/Neg 2 WLSH
d-Dimer (quantitative)
Analyte Fluid Method Limit Source
d-Dimer (quantitative) 2 SD 2 WLSH
d-Dimer (semi-quantitative)
Analyte Fluid Method Limit Source
d-Dimer (semi-quantitative) Pos/Neg 2 WLSH
Dehydroepiandrosterone sulfate
Analyte Fluid Method Limit Source
Dehydroepiandrosterone sulfate S- 22.2% 5 BV
Deoxipyridinoline/creatinine, 24h
Analyte Fluid Method Limit Source
Deoxipyridinoline/creatinine, 24h U- 21.2% 5 BV
Deoxipyridinoline/creatinine, morning sp
Analyte Fluid Method Limit Source
Deoxipyridinoline/creatinine, morning sp U- 33% 5 BV
Desipramine
Analyte Fluid Method Limit Source
Desipramine 15% 8 CFX
DHEA Sulfate
Analyte Fluid Method Limit Source
DHEA Sulfate 2.5 SD 2 WLSH
DHEA Sulphate
Analyte Fluid Method Limit Source
DHEA Sulphate 1.0 umol/L, 10% 7 RCPA
DHEA Sulphate 2 SD 8 CFX
Digoxin
Analyte Fluid Method Limit Source
Digoxin +/- 20% or 0.2 ng/mL (greater) 1 CLIA, 2 WLSH, 6 AAB
Digoxin 15% or 0.2 ng/mL 3 NYS
Digoxin Centaur 20% or 0.2 ng/mL (greater) 4 CAP
Digoxin 0.2 nmol/L, 10% 7 RCPA
Digoxin 25% 8 CFX
Dipeptidyl-peptidase IV
Analyte Fluid Method Limit Source
Dipeptidyl-peptidase IV P- 10.9% 5 BV
Direct Bilirubin
Analyte Fluid Method Limit Source
Direct Bilirubin 0.4 mg/dL or 20% 6 AAB
Disopyramide
Analyte Fluid Method Limit Source
Disopyramide 2.0 umol/L, 10% 7 RCPA
Disopyramide 15% 8 CFX
DMF
Analyte Fluid Method Limit Source
DMF 0.45 mmol/L or 30% 6 AAB
Dopamine
Analyte Fluid Method Limit Source
Dopamine 0.25 umol/day, 25% 7 RCPA
DPD (Free)-Urine
Analyte Fluid Method Limit Source
DPD (Free)-Urine U- 15 nmol/L, 15% 7 RCPA
DPD (Total)-Urine
Analyte Fluid Method Limit Source
DPD (Total)-Urine U- 15 nmol/L, 15% 7 RCPA
Elastase-Pl
Analyte Fluid Method Limit Source
Elastase-Pl P- 16.5% 5 BV
Eosinophils, count
Analyte Fluid Method Limit Source
Eosinophils, count B- 37.1% 5 BV
EP:
Analyte Fluid Method Limit Source
EP: +/-6 µg/dL (values <40µg/dL) or +/-15% (values >40µg/dL) 3 NYS
Erythrocites, count
Analyte Fluid Method Limit Source
Erythrocites, count B- 4.4% 5 BV
Erythrocyte count
Analyte Fluid Method Limit Source
Erythrocyte count +/- 6% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Erythrocyte Sedimentation Rate (ESR)
Analyte Fluid Method Limit Source
Erythrocyte Sedimentation Rate (ESR) 3SD 6 AAB
Erythrocyte Sedimentation Rate (ESR) - Rapid
Analyte Fluid Method Limit Source
Erythrocyte Sedimentation Rate (ESR) - Rapid 3SD 6 AAB
Erythrocytes
Analyte Fluid Method Limit Source
Erythrocytes 6% 6 AAB
Estradiol
Analyte Fluid Method Limit Source
Estradiol 3 ng/mL or 30% 2 WLSH
Estradiol +/-25% or 30 pg/mL 3 NYS
Estradiol U- 27% 5 BV
Estradiol 3 pg/mL or 30% 6 AAB
Estradiol 2 SD 8 CFX
Estriol
Analyte Fluid Method Limit Source
Estriol 2.5 SD 2 WLSH
Estriol - Total
Analyte Fluid Method Limit Source
Estriol - Total 2 SD 8 CFX
Estriol - Unconjugated
Analyte Fluid Method Limit Source
Estriol - Unconjugated 2 SD 8 CFX
Estrogen
Analyte Fluid Method Limit Source
Estrogen 2.5 SD 2 WLSH
Ethanol
Analyte Fluid Method Limit Source
Ethanol 20% or 2 SD 3 NYS
Ethanol Abbott AxSym 80% consensus 4 CAP
Ethanol 15% 8 CFX
Ethanol, Blood
Analyte Fluid Method Limit Source
Ethanol, Blood HP GLC 25% 4 CAP
Ethanol, Urine
Analyte Fluid Method Limit Source
Ethanol, Urine HP GLC 25% or 9 mg/dL (greater) 4 CAP
Ethosuximide
Analyte Fluid Method Limit Source
Ethosuximide +/- 20% 1 CLIA, 2 WLSH
Ethosuximide +/- 15% 3 NYS
Ethosuximide 3 umol/L, 10% 7 RCPA
Ethosuximide 15% 8 CFX
Factor VII coagulation
Analyte Fluid Method Limit Source
Factor VII coagulation P- 10.7% 5 BV
Factor VIII coagulation
Analyte Fluid Method Limit Source
Factor VIII coagulation P- 8.9% 5 BV
Faecal Percent Dry Weight
Analyte Fluid Method Limit Source
Faecal Percent Dry Weight 1, 10% 7 RCPA
Faecal Total Porphyrin
Analyte Fluid Method Limit Source
Faecal Total Porphyrin 15 umol/kg, 15% 7 RCPA
Fentanyl
Analyte Fluid Method Limit Source
Fentanyl 20% or 2 SD 3 NYS
Ferritin
Analyte Fluid Method Limit Source
Ferritin 4.5 ng/mL or 30% 2 WLSH
Ferritin Centaur 3 SD 4 CAP
Ferritin 4.5 ng/mL or 30% 6 AAB
Ferritin 6.0 ug/L, 15% 7 RCPA
Ferritin 19.3% 8 CFX
Ferritine
Analyte Fluid Method Limit Source
Ferritine S- 17.3% 5 BV
Fibrinogen
Analyte Fluid Method Limit Source
Fibrinogen +/- 20% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Fibrinogen P- 13.6% 5 BV
Folate
Analyte Fluid Method Limit Source
Folate 0.9 ng/mL or 30% 2 WLSH
Folate S- 39% 5 BV
Folate (B)Erthry- 26.7% 5 BV
Folate 0.9 ng/mL or 30% 6 AAB
Folate 1.0 umol/day, 30% 7 RCPA
Folate 2 SD 8 CFX
Folate, Serum
Analyte Fluid Method Limit Source
Folate, Serum Centaur 3 SD 4 CAP
Folic Acid
Analyte Fluid Method Limit Source
Folic Acid +/- 30% or 2.0 ng/mL 3 NYS
Follicle stimulating hormone
Analyte Fluid Method Limit Source
Follicle stimulating hormone S- 16.7% 5 BV
Follicle Stimulating Hormone
Analyte Fluid Method Limit Source
Follicle Stimulating Hormone 2 SD 8 CFX
Follicle-Stimulating Hormone
Analyte Fluid Method Limit Source
Follicle-Stimulating Hormone 2 mIU/mL or 25% 6 AAB
fPSA
Analyte Fluid Method Limit Source
fPSA +/- 3 SD 3 NYS
Fractional Carboxyhemoglobin
Analyte Fluid Method Limit Source
Fractional Carboxyhemoglobin 0.02 7 RCPA
Fractional Methemoglobin
Analyte Fluid Method Limit Source
Fractional Methemoglobin 1.0, 10% 7 RCPA
Fractional Oxyhemoglobin
Analyte Fluid Method Limit Source
Fractional Oxyhemoglobin 3, 4% 7 RCPA
Free Estriol
Analyte Fluid Method Limit Source
Free Estriol +/-25% or 3.0 ng/mL 3 NYS
Free phenytoin
Analyte Fluid Method Limit Source
Free phenytoin +/- 20% 3 NYS
Free PSA
Analyte Fluid Method Limit Source
Free PSA 1.5 ug/L, 15% 7 RCPA
Free T3
Analyte Fluid Method Limit Source
Free T3 3 SD 2 WLSH
Free T3 3.0 pmol/L 7 RCPA
Free T4 (Endocrinology)
Analyte Fluid Method Limit Source
Free T4 (Endocrinology) 1.5 pmol/L, 15% 7 RCPA
Free T4 (General Chemistry)
Analyte Fluid Method Limit Source
Free T4 (General Chemistry) 3 pmol/L, 15% 7 RCPA
Free thyroxine
Analyte Fluid Method Limit Source
Free thyroxine +/- 3 SD 1 CLIA, 2 WLSH, 3 NYS
Free thyroxine (FT4)
Analyte Fluid Method Limit Source
Free thyroxine (FT4) S- 9.9% 5 BV
Fructosamine
Analyte Fluid Method Limit Source
Fructosamine S- 4.5% 5 BV
Fructosamine 30 umol/L, 10% 7 RCPA
FSH
Analyte Fluid Method Limit Source
FSH +/-25% 3 NYS
FSH Centaur 3 SD 4 CAP
FSH 4.0 IU/L, 20% 7 RCPA
FSH 2 mIU/mL or 25% 2 WLSH
g-Globulins
Analyte Fluid Method Limit Source
g-Globulins S- 16.8% 5 BV
g-glutamyltransferase
Analyte Fluid Method Limit Source
g-glutamyltransferase S- 22.2% 5 BV
Galactosy hydroxylisine
Analyte Fluid Method Limit Source
Galactosy hydroxylisine S- 16.8% 5 BV
Gamma glutamyltransferase
Analyte Fluid Method Limit Source
Gamma glutamyltransferase +/- 30% 3 NYS
Gamma-glutamyl transferase [GGT]
Analyte Fluid Method Limit Source
Gamma-glutamyl transferase [GGT] 20% 2 WLSH
gamma-Glutamyl-transferase
Analyte Fluid Method Limit Source
gamma-Glutamyl-transferase 10 IU/L or 20% 6 AAB
Gamma-Glutamyltransferase
Analyte Fluid Method Limit Source
Gamma-Glutamyltransferase 30% 8 CFX
Gastrin
Analyte Fluid Method Limit Source
Gastrin 25 pmol/L, 10% 7 RCPA
Gentamicin
Analyte Fluid Method Limit Source
Gentamicin +/- 25% 1 CLIA, 2 WLSH, 6 AAB
Gentamicin +/- 15% 3 NYS
Gentamicin Abbott AxSym 25% 4 CAP
Gentamicin 0.5 mg/L, 10% 7 RCPA
Gentamicin 20% 8 CFX
GGT
Analyte Fluid Method Limit Source
GGT AU640 3 SD 4 CAP
GGT 8 U/L, 15% 7 RCPA
Globulins, total
Analyte Fluid Method Limit Source
Globulins, total S- 8% 5 BV
Glucose
Analyte Fluid Method Limit Source
Glucose +/- 6 mg/dL or +/- 10% (greater) 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Glucose Radiometer 725 10% or 6 mg/dL (greater) 4 CAP
Glucose AU640 10% or 6 mg/dL (greater) 4 CAP
Glucose S- 6.3% 5 BV
Glucose 0.5 mmol/L, 10% 7 RCPA
Glucose (GLUC )
Analyte Fluid Method Limit Source
Glucose (GLUC ) 0.3 mmol/L, 8.0% 8 CFX
Glucose -urine
Analyte Fluid Method Limit Source
Glucose -urine U- 10% 2 WLSH
Glucose, CSF
Analyte Fluid Method Limit Source
Glucose, CSF 10% 2 WLSH
Glucose, Urine
Analyte Fluid Method Limit Source
Glucose, Urine AU640 10% or 6 g/24 hs (greater) 4 CAP
Glucose, Urine (qual)
Analyte Fluid Method Limit Source
Glucose, Urine (qual) 80% Agreement 3 NYS
Glucose, Whole Blood
Analyte Fluid Method Limit Source
Glucose, Whole Blood 20 mg/dL or 20% 2 WLSH
Glucose-6-phosphate-1-dehydrogenase
Analyte Fluid Method Limit Source
Glucose-6-phosphate-1-dehydrogenase (B)Erythr- 38.5% 5 BV
Glucose-Blood Gas
Analyte Fluid Method Limit Source
Glucose-Blood Gas BG 1.0 mmol/day, 10% 7 RCPA
Glucose-CSF
Analyte Fluid Method Limit Source
Glucose-CSF CSF 1.0 mmol/L, 10% 7 RCPA
Glucose-Urine
Analyte Fluid Method Limit Source
Glucose-Urine U- 1.0 mmol/L, 10% 7 RCPA
Glutathione peroxidase
Analyte Fluid Method Limit Source
Glutathione peroxidase S- 11.7% 5 BV
Glycated albumin
Analyte Fluid Method Limit Source
Glycated albumin S- 7.2% 5 BV
Glycated Hemoglobin A1c
Analyte Fluid Method Limit Source
Glycated Hemoglobin A1c 9% 8 CFX
Glycated total protein
Analyte Fluid Method Limit Source
Glycated total protein S- 3.7% 5 BV
Glycohemoglobin
Analyte Fluid Method Limit Source
Glycohemoglobin 1.00% or 25% 6 AAB
Growth Hormone
Analyte Fluid Method Limit Source
Growth Hormone 2 mU/L, 20% 7 RCPA
Haptoglobin
Analyte Fluid Method Limit Source
Haptoglobin BNII not evaluated 4 CAP
Haptoglobin P, S- 27.3% 5 BV
hCG
Analyte Fluid Method Limit Source
hCG 32% 8 CFX
hCG (Maternal Sera)
Analyte Fluid Method Limit Source
hCG (Maternal Sera) +/- 3 SD 3 NYS
hCG, Quant
Analyte Fluid Method Limit Source
hCG, Quant Centaur 3 SD 4 CAP
hCG,qualitative (serum)
Analyte Fluid Method Limit Source
hCG,qualitative (serum) Pos/Neg 2 WLSH
hCG-quantitative
Analyte Fluid Method Limit Source
hCG-quantitative 3.0 IU/L, 15% 7 RCPA
hCG-quantitative-Urine
Analyte Fluid Method Limit Source
hCG-quantitative-Urine U- 5 IU/L, 10% 7 RCPA
HDL 1 cholesterol
Analyte Fluid Method Limit Source
HDL 1 cholesterol S- 11.5% 5 BV
HDL 2 cholesterol
Analyte Fluid Method Limit Source
HDL 2 cholesterol S- 23.9% 5 BV
HDL 3 cholesterol
Analyte Fluid Method Limit Source
HDL 3 cholesterol S- 9.8% 5 BV
HDL cholesterol
Analyte Fluid Method Limit Source
HDL cholesterol S- 11.1% 5 BV
HDL Cholesterol
Analyte Fluid Method Limit Source
HDL Cholesterol 30% 6 AAB
HDL Cholesterol 0.20 mmol/L, 10% 7 RCPA
HDL- Cholesterol
Analyte Fluid Method Limit Source
HDL- Cholesterol AU640 30% 4 CAP
Hematocrit
Analyte Fluid Method Limit Source
Hematocrit +/- 6% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Hematocrit B- 4.1% 5 BV
Hemoglobin
Analyte Fluid Method Limit Source
Hemoglobin +/- 7% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Hemoglobin B- 4.1% 5 BV
Hemoglobin A1 C
Analyte Fluid Method Limit Source
Hemoglobin A1 C S- 4.4% 5 BV
Hemoglobin A1c
Analyte Fluid Method Limit Source
Hemoglobin A1c 1.0 or 25% 2 WLSH
Hemoglobin A1C
Analyte Fluid Method Limit Source
Hemoglobin A1C 0.5, 5% 7 RCPA
Hemoglobin concentration
Analyte Fluid Method Limit Source
Hemoglobin concentration 3 g/L, 3% 7 RCPA
Hemoglobin, Urine (qual)
Analyte Fluid Method Limit Source
Hemoglobin, Urine (qual) 80% Agreement 3 NYS
Hemoglobin,total
Analyte Fluid Method Limit Source
Hemoglobin,total 7% 2 WLSH
Hemoglobin,Total A1
Analyte Fluid Method Limit Source
Hemoglobin,Total A1 1.0 or 25% 2 WLSH
Hepatitis (Anti-HBc HBsAg HBeAg Anti-HCV )
Analyte Fluid Method Limit Source
Hepatitis (Anti-HBc HBsAg HBeAg Anti-HCV ) Reactive (Positive) or Nonreactive (Negative) 3 NYS
Hepatitis (HBsAg, anti-HBc, HBeAg)
Analyte Fluid Method Limit Source
Hepatitis (HBsAg, anti-HBc, HBeAg) Reactive (positive) or nonreactive (negative) 1 CLIA
Heterophile
Analyte Fluid Method Limit Source
Heterophile Positive or Negative or +/- 2 dilutions 3 NYS
high sensitivity CRP
Analyte Fluid Method Limit Source
high sensitivity CRP 0.4 mg/L or 3 SD% 6 AAB
HMMA
Analyte Fluid Method Limit Source
HMMA 20 umol/day, 20% 7 RCPA
Homocysteine
Analyte Fluid Method Limit Source
Homocysteine Non-graded analyte 3 NYS
Homocysteine IMX 3 SD 4 CAP
Homocysteine P- 17.7% 5 BV
Homocysteine 2.5 umol/L or 20% 6 AAB
Homocysteine 15% 8 CFX
hS-CRP
Analyte Fluid Method Limit Source
hS-CRP 2.0 SD 2 WLSH
hs-CRP
Analyte Fluid Method Limit Source
hs-CRP BNII not evaluated 4 CAP
Human Chorionic Gonadotropin
Analyte Fluid Method Limit Source
Human Chorionic Gonadotropin 3SD 6 AAB
Human chorionic gonadotropin
Analyte Fluid Method Limit Source
Human chorionic gonadotropin +/- 3 SD or (positive or negative) 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
HVA
Analyte Fluid Method Limit Source
HVA 8 umol/day, 25% 7 RCPA
Hydroxiproline/creatinine
Analyte Fluid Method Limit Source
Hydroxiproline/creatinine S- 32.9% 5 BV
Hydroxiproline/minute, night urine
Analyte Fluid Method Limit Source
Hydroxiproline/minute, night urine U- 43% 5 BV
Hydroxyproline-Urine
Analyte Fluid Method Limit Source
Hydroxyproline-Urine U- 10 umol/L, 10% 7 RCPA
IBC - Total
Analyte Fluid Method Limit Source
IBC - Total 25% 8 CFX
IBC - Unsaturated
Analyte Fluid Method Limit Source
IBC - Unsaturated 2 SD 8 CFX
IgA
Analyte Fluid Method Limit Source
IgA +/- 3 SD 1 CLIA, 3 NYS, 6 AAB
IgA, Blood
Analyte Fluid Method Limit Source
IgA, Blood BNII 3 SD 4 CAP
IgB
Analyte Fluid Method Limit Source
IgB +/- 3 SD 1 CLIA
IgE
Analyte Fluid Method Limit Source
IgE +/- 3 SD 3 NYS
IgE 3SD 6 AAB
IgE Opt 3SD 6 AAB
IgE 4.0 IU/L, 20% 7 RCPA
IGF-1
Analyte Fluid Method Limit Source
IGF-1 3 nmol/L, 15% 7 RCPA
IgG
Analyte Fluid Method Limit Source
IgG +/- 25% 1 CLIA, 3 NYS, 6 AAB
IgG, Blood
Analyte Fluid Method Limit Source
IgG, Blood BNII 25% 4 CAP
IgG-Blood
Analyte Fluid Method Limit Source
IgG-Blood BNII 3 SD 4 CAP
IgG-CSF
Analyte Fluid Method Limit Source
IgG-CSF BNII 3 SD 4 CAP
IgM
Analyte Fluid Method Limit Source
IgM +/- 3 SD 1 CLIA, 3 NYS, 6 AAB
IgM, Blood
Analyte Fluid Method Limit Source
IgM, Blood BNII 3 SD 4 CAP
Imipramine
Analyte Fluid Method Limit Source
Imipramine 15% 8 CFX
Immunofix Urine
Analyte Fluid Method Limit Source
Immunofix Urine Sebia Hydrasis LS 90% consensus 4 CAP
Immunofixation Serum
Analyte Fluid Method Limit Source
Immunofixation Serum Sebia Hydrasis LS 90% consensus 4 CAP
Immunoglobin G-CSF
Analyte Fluid Method Limit Source
Immunoglobin G-CSF CSF 0.1 g/L, 10% 7 RCPA
Immunoglobulin A
Analyte Fluid Method Limit Source
Immunoglobulin A S- 13.5% 5 BV
Immunoglobulin G
Analyte Fluid Method Limit Source
Immunoglobulin G S- 8% 5 BV
Immunoglobulin M
Analyte Fluid Method Limit Source
Immunoglobulin M S- 16.8% 5 BV
Immunoglobulins K chain
Analyte Fluid Method Limit Source
Immunoglobulins K chain S- 8% 5 BV
Immunoglobulins l chain
Analyte Fluid Method Limit Source
Immunoglobulins l chain S- 8.6% 5 BV
Infectious mononucleosis
Analyte Fluid Method Limit Source
Infectious mononucleosis Target value +/- 2 dilution or (pos. or neg.) 1 CLIA
INR
Analyte Fluid Method Limit Source
INR 2 SD 2 WLSH
Insulin
Analyte Fluid Method Limit Source
Insulin +/-25% or 3.0 uU/mL 3 NYS
Insulin S- 32.9% 5 BV
Insulin 5 mU/L, 25% 7 RCPA
Interferon receptor
Analyte Fluid Method Limit Source
Interferon receptor (B)Leuc- 17.7% 5 BV
Interleukin-1B
Analyte Fluid Method Limit Source
Interleukin-1B S- 36.5% 5 BV
Interleukin-8
Analyte Fluid Method Limit Source
Interleukin-8 S- 29.6% 5 BV
Ionised Calcium
Analyte Fluid Method Limit Source
Ionised Calcium 0.05 mmol/L 7 RCPA
Ionized Calcium
Analyte Fluid Method Limit Source
Ionized Calcium 0.13 mmol/L 2 WLSH
Ionized Calcium 0.25 mmol/L 6 AAB
Iron
Analyte Fluid Method Limit Source
Iron AU640 20% 4 CAP
Iron (B)Leuc- 30.7% 5 BV
Iron 20% 6 AAB
Iron 5 umol/L 7 RCPA
Iron 31% 8 CFX
Iron binding capacity
Analyte Fluid Method Limit Source
Iron binding capacity 20% 2 WLSH
Iron Binding Capacity
Analyte Fluid Method Limit Source
Iron Binding Capacity AU640 20% 4 CAP
Iron Saturation
Analyte Fluid Method Limit Source
Iron Saturation Calculated 3 SD 4 CAP
Iron, total
Analyte Fluid Method Limit Source
Iron, total +/- 20% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Isopropanol
Analyte Fluid Method Limit Source
Isopropanol HP GLC not evaluated 4 CAP
Ketones, Urine (qual)
Analyte Fluid Method Limit Source
Ketones, Urine (qual) 80% Agreement 3 NYS
Lactate
Analyte Fluid Method Limit Source
Lactate 0.2 mmol/L or 2SD 2 WLSH
Lactate Radiometer 725 4 CAP
Lactate AU640 2 SD 4 CAP
Lactate B- 30.4% 5 BV
Lactate 1.0 mmol/L, 10% 7 RCPA
Lactate 1.0 mmol/day, 10% 7 RCPA
Lactate 30% 8 CFX
Lactate Dehydrogenase
Analyte Fluid Method Limit Source
Lactate Dehydrogenase AU640 20% 4 CAP
Lactate Dehydrogenase 20% 6 AAB
Lactate Dehydrogenase 30 U/L, 15% 7 RCPA
Lactate Dehydrogenase 20% 8 CFX
Lactate dehydrogenase (LDH)
Analyte Fluid Method Limit Source
Lactate dehydrogenase (LDH) +/- 20% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Lactate dehydrogenase (LDH) S- 11.4% 5 BV
Lactate dehydrogenase 1 isoform (LDH1)
Analyte Fluid Method Limit Source
Lactate dehydrogenase 1 isoform (LDH1) S- 8.2% 5 BV
Lactate dehydrogenase 2 isoform (LDH2)
Analyte Fluid Method Limit Source
Lactate dehydrogenase 2 isoform (LDH2) S- 5.7% 5 BV
Lactate dehydrogenase 3 isoform (LDH3)
Analyte Fluid Method Limit Source
Lactate dehydrogenase 3 isoform (LDH3) S- 5.8% 5 BV
Lactate dehydrogenase 4 isoform (LDH4)
Analyte Fluid Method Limit Source
Lactate dehydrogenase 4 isoform (LDH4) S- 11% 5 BV
Lactate dehydrogenase 5 isoform (LDH5)
Analyte Fluid Method Limit Source
Lactate dehydrogenase 5 isoform (LDH5) S- 14.8% 5 BV
Lactate-CSF
Analyte Fluid Method Limit Source
Lactate-CSF CSF 0.1 mmol/L, 10% 7 RCPA
Lactoferrin
Analyte Fluid Method Limit Source
Lactoferrin P- 16.4% 5 BV
Lactoferrin Opt 0.5 mg/mL or 20% 6 AAB
LD Isoenzymes 3-5
Analyte Fluid Method Limit Source
LD Isoenzymes 3-5 3.00% or 30% 6 AAB
LDH isoenzymes
Analyte Fluid Method Limit Source
LDH isoenzymes LDH1/LDH2 (+ or -) or Target value +/- 30% 1 CLIA, 3 NYS
LDL Cholesterol
Analyte Fluid Method Limit Source
LDL Cholesterol S- 13.6% 5 BV
LDL Cholesterol (Direct)
Analyte Fluid Method Limit Source
LDL Cholesterol (Direct) 15 mg/dL or 20% 6 AAB
LDL receptor mRNA
Analyte Fluid Method Limit Source
LDL receptor mRNA S- 24.1% 5 BV
LDL- Cholesterol
Analyte Fluid Method Limit Source
LDL- Cholesterol AU640 20% 4 CAP
Lead, Blood
Analyte Fluid Method Limit Source
Lead, Blood Spectra AA 10% or 4 ug/dL (greater) 4 CAP
Leukocyte count
Analyte Fluid Method Limit Source
Leukocyte count +/- 15% 1 CLIA
Leukocytes
Analyte Fluid Method Limit Source
Leukocytes 15% 6 AAB
Leukocytes, count
Analyte Fluid Method Limit Source
Leukocytes, count P- 14.6% 5 BV
LH
Analyte Fluid Method Limit Source
LH 2.5 SD 2 WLSH
LH +/-25% or 1.5 IU/L 3 NYS
LH Centaur 3 SD 4 CAP
LH 2.0 IU/L, 20% 7 RCPA
Lignocaine
Analyte Fluid Method Limit Source
Lignocaine 2.0 umol/L, 10% 7 RCPA
Lipase
Analyte Fluid Method Limit Source
Lipase 30% 2 WLSH
Lipase AU640 30% 4 CAP
Lipase S- 29.1% 5 BV
Lipase 30% 6 AAB
Lipase 40 U/L, 20% 7 RCPA
Lipase 37% 8 CFX
Lipoprotein (a)
Analyte Fluid Method Limit Source
Lipoprotein (a) S- 28.8% 5 BV
Lipoprotein (a) 10 mg/dL or 30% 6 AAB
Lipoprotein (a) 2 SD 8 CFX
Lithium
Analyte Fluid Method Limit Source
Lithium +/- 20% or 0.3 mmol/L 1 CLIA, 2 WLSH, 6 AAB
Lithium +/- 15% or 0.3 mmol/L 3 NYS
Lithium AVL 9180 20% or 0.3 mEq/L (greater) 4 CAP
Lithium 0.2 mmol/L 7 RCPA
Lithium 10% 8 CFX
Luteinizing hormone
Analyte Fluid Method Limit Source
Luteinizing hormone S- 19.8% 5 BV
Luteinizing Hormone
Analyte Fluid Method Limit Source
Luteinizing Hormone 2 mIU/mL or 25% 6 AAB
Luteinizing Hormone 2 SD 8 CFX
Lymphocytes, count
Analyte Fluid Method Limit Source
Lymphocytes, count B- 16% 5 BV
M-Protein Interpr.
Analyte Fluid Method Limit Source
M-Protein Interpr. Sebia Hydrasis LS 90% consensus 4 CAP
Magnesium
Analyte Fluid Method Limit Source
Magnesium +/- 25% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Magnesium AU640 25% 4 CAP
Magnesium S- 4.8% 5 BV
Magnesium (B)Leuc- 21.2% 5 BV
Magnesium (B)Erythr- 7.8% 5 BV
Magnesium 3 mmol/L 7 RCPA
Magnesium 0.1 mmol/L, 12% 8 CFX
Magnesium (serum)
Analyte Fluid Method Limit Source
Magnesium (serum) U- 0.12 mmol/L 7 RCPA
Magnesium - Ionized
Analyte Fluid Method Limit Source
Magnesium - Ionized 10% 8 CFX
Magnesium - urine
Analyte Fluid Method Limit Source
Magnesium - urine U- 25% 2 WLSH
Magnesium, concentration, 24h
Analyte Fluid Method Limit Source
Magnesium, concentration, 24h U- 52.2% 5 BV
Magnesium, ionized
Analyte Fluid Method Limit Source
Magnesium, ionized U- 2.9% 5 BV
Magnesium, output, 24h
Analyte Fluid Method Limit Source
Magnesium, output, 24h U- 45% 5 BV
Magnesium, urine
Analyte Fluid Method Limit Source
Magnesium, urine U- AU640 25% 4 CAP
MCV
Analyte Fluid Method Limit Source
MCV 3 SD 2 WLSH
Mean corpuscular hemoglobin (HCM)
Analyte Fluid Method Limit Source
Mean corpuscular hemoglobin (HCM) (B)Erythr- 2.7% 5 BV
Mean corpuscular hemoglobin concentratio
Analyte Fluid Method Limit Source
Mean corpuscular hemoglobin concentratio (B)Erythr- 2.2% 5 BV
Mean corpuscular volume (MCV)
Analyte Fluid Method Limit Source
Mean corpuscular volume (MCV) (B)Erythr- 2.3% 5 BV
Mean platelet volume (MPV)
Analyte Fluid Method Limit Source
Mean platelet volume (MPV) (B)Plat- 5.8% 5 BV
Metanephrine
Analyte Fluid Method Limit Source
Metanephrine 0.5 umol/day, 33% 7 RCPA
Methadone
Analyte Fluid Method Limit Source
Methadone Pos/Neg 2 WLSH
Methadone 20% or 2 SD 3 NYS
Methanol
Analyte Fluid Method Limit Source
Methanol HP GLC not evaluated 4 CAP
Methemoglobin
Analyte Fluid Method Limit Source
Methemoglobin 3 SD 2 WLSH
Methemoglobin Radiometer 725 2% 4 CAP
Methotrexate
Analyte Fluid Method Limit Source
Methotrexate 0.1 umol/L, 10% 7 RCPA
Methotrexate 25% 8 CFX
Methqualone
Analyte Fluid Method Limit Source
Methqualone Pos/Neg 2 WLSH
Microalbumin - quantitative
Analyte Fluid Method Limit Source
Microalbumin - quantitative 2.5 SD 2 WLSH
Microalbumin, urine
Analyte Fluid Method Limit Source
Microalbumin, urine U- AU640 3 SD 4 CAP
Monocytes, count
Analyte Fluid Method Limit Source
Monocytes, count B- 27.9% 5 BV
MSAFP
Analyte Fluid Method Limit Source
MSAFP Centaur 3 SD 4 CAP
MShCG
Analyte Fluid Method Limit Source
MShCG Centaur 3 SD 4 CAP
Mucinous carcinoma-associated antigen (M
Analyte Fluid Method Limit Source
Mucinous carcinoma-associated antigen (M S- 18.5% 5 BV
Myoglobin
Analyte Fluid Method Limit Source
Myoglobin S- 19.6% 5 BV
Myoglobin 15 ng/mL or 30% 6 AAB
Myoglobin 30% 8 CFX
Myoglobin - qualitative
Analyte Fluid Method Limit Source
Myoglobin - qualitative Pos/Neg 2 WLSH
Myoglobin - quantitative
Analyte Fluid Method Limit Source
Myoglobin - quantitative 2 SD 2 WLSH
N-Acetyl Glucosaminidase, concentration,
Analyte Fluid Method Limit Source
N-Acetyl Glucosaminidase, concentration, U- 53.1% 5 BV
N-Acetyl Glucosaminidase, output
Analyte Fluid Method Limit Source
N-Acetyl Glucosaminidase, output U- 46.5% 5 BV
N-acetyl procainamide
Analyte Fluid Method Limit Source
N-acetyl procainamide +/- 15% 3 NYS
N-acetylprocainamide
Analyte Fluid Method Limit Source
N-acetylprocainamide Abbott AxSym 25% 4 CAP
N-acetylprocainamide 20% 8 CFX
N-Telopeptides-Urine
Analyte Fluid Method Limit Source
N-Telopeptides-Urine U- 80 nmolBCE/L, 10% 7 RCPA
Napa
Analyte Fluid Method Limit Source
Napa Abbott AxSym 25% 4 CAP
Neutrophyles, count
Analyte Fluid Method Limit Source
Neutrophyles, count B- 22.4% 5 BV
Nitrogen, output
Analyte Fluid Method Limit Source
Nitrogen, output U- 18.4% 5 BV
Noradrenaline
Analyte Fluid Method Limit Source
Noradrenaline 50 nmol/day, 10% 7 RCPA
Normetanephrine
Analyte Fluid Method Limit Source
Normetanephrine 1.0 umol/day, 33% 7 RCPA
Nortriptyline
Analyte Fluid Method Limit Source
Nortriptyline 10 nmol/L, 10% 7 RCPA
Nortriptyline 15% 8 CFX
NSE
Analyte Fluid Method Limit Source
NSE 2.0 ug/L, 10% 7 RCPA
Oestradiol
Analyte Fluid Method Limit Source
Oestradiol 100 pmol/L, 20% 7 RCPA
Oestriol(total)
Analyte Fluid Method Limit Source
Oestriol(total) 20 nmol/L, 10% 7 RCPA
Oestriol(unconjugated)
Analyte Fluid Method Limit Source
Oestriol(unconjugated) 5 nmol/L, 20% 7 RCPA
Oligoclonal Bands
Analyte Fluid Method Limit Source
Oligoclonal Bands Sebia Hydrasis LS 90% consensus 4 CAP
Opiate
Analyte Fluid Method Limit Source
Opiate Abbott AxSym 80% consensus 4 CAP
Opiates
Analyte Fluid Method Limit Source
Opiates Pos/Neg 2 WLSH
Opiates 20% or 2 SD 3 NYS
Osmolality
Analyte Fluid Method Limit Source
Osmolality Freezing point 2 SD 4 CAP
Osmolality S- 1.5% 5 BV
Osmolality U- 9. mOsm/kg or 10% 6 AAB
Osmolality 8 mmol/kg 7 RCPA
Osmolality 3% 8 CFX
Osmolality, urine
Analyte Fluid Method Limit Source
Osmolality, urine U- Freezing point 3 SD 4 CAP
Osmolality,serum
Analyte Fluid Method Limit Source
Osmolality,serum 3 SD 2 WLSH
Osmolality,urine
Analyte Fluid Method Limit Source
Osmolality,urine U- 3 SD 2 WLSH
Osmolality-Urine
Analyte Fluid Method Limit Source
Osmolality-Urine U- 6 mmol/kg, 2% 7 RCPA
Osteocalcin
Analyte Fluid Method Limit Source
Osteocalcin S- 11.2% 5 BV
Oxalate, concentration
Analyte Fluid Method Limit Source
Oxalate, concentration U- 48.2% 5 BV
Oxalate, output
Analyte Fluid Method Limit Source
Oxalate, output U- 46.8% 5 BV
Oxyhemoglobin
Analyte Fluid Method Limit Source
Oxyhemoglobin 3 SD 2 WLSH
Oxyhemoglobin Radiometer 725 4 CAP
PAP
Analyte Fluid Method Limit Source
PAP 2.5 SD 2 WLSH
Paracetamol
Analyte Fluid Method Limit Source
Paracetamol 20 umol/L, 10% 7 RCPA
Partial thromboplastin time
Analyte Fluid Method Limit Source
Partial thromboplastin time +/- 15% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
pCO2
Analyte Fluid Method Limit Source
pCO2 Radiometer 725 8% or 5 mm Hg (greater) 4 CAP
pCO2 B- 5.7% 5 BV
pCO2 5.0 mm Hg or 8% 6 AAB
pCO2 2.0 mm Hg, 8% 7 RCPA
pCO2 5 kPa, 8% 8 CFX
pH
Analyte Fluid Method Limit Source
pH Radiometer 725 0.04 4 CAP
pH 0.04 6 AAB
pH 0.04 7 RCPA
pH 0.04 8 CFX
pH [H+]
Analyte Fluid Method Limit Source
pH [H+] B- 3.9% 5 BV
pH, Urine (qual)
Analyte Fluid Method Limit Source
pH, Urine (qual) 80% Agreement 3 NYS
pH,Fluid
Analyte Fluid Method Limit Source
pH,Fluid Corning 445 pH meter 0.04 4 CAP
Phencyclidine
Analyte Fluid Method Limit Source
Phencyclidine Pos/Neg 2 WLSH
Phencyclidine 20% or 2 SD 3 NYS
Phencyclidine Abbott AxSym 80% consensus 4 CAP
Phenobarbital
Analyte Fluid Method Limit Source
Phenobarbital +/- 20% 1 CLIA, 2 WLSH, 6 AAB
Phenobarbital +/- 15% 3 NYS
Phenobarbital Abbott AxSym 20% 4 CAP
Phenobarbital 20% 8 CFX
Phenobarbitone
Analyte Fluid Method Limit Source
Phenobarbitone 3.0 umol/L, 10% 7 RCPA
Phenytoin
Analyte Fluid Method Limit Source
Phenytoin +/- 25% 1 CLIA, 2 WLSH, 6 AAB
Phenytoin +/- 15% 3 NYS
Phenytoin Abbott AxSym 25% 4 CAP
Phenytoin 3.0 umol/L, 10% 7 RCPA
Phenytoin 25% 8 CFX
Phenytoin, free
Analyte Fluid Method Limit Source
Phenytoin, free TDX 3 SD 4 CAP
Phosphate
Analyte Fluid Method Limit Source
Phosphate S- 10.2% 5 BV
Phosphate 0.1 mmol/L, 10% 7 RCPA
Phosphate tubular reabsorption
Analyte Fluid Method Limit Source
Phosphate tubular reabsorption Patient- 3.3% 5 BV
Phosphate, concentration
Analyte Fluid Method Limit Source
Phosphate, concentration U- 31.1% 5 BV
Phosphate, output
Analyte Fluid Method Limit Source
Phosphate, output U- 22.1% 5 BV
Phosphate-Urine
Analyte Fluid Method Limit Source
Phosphate-Urine U- 2.5 mmol/L 7 RCPA
Phospholipids
Analyte Fluid Method Limit Source
Phospholipids S- 8.6% 5 BV
Phosphorus
Analyte Fluid Method Limit Source
Phosphorus 0.5 mg/dL or 12% 2 WLSH
Phosphorus +/- 0.45 mg/dL or 13% 3 NYS
Phosphorus AU640 10.7% or 0.3 mg/dL (greater) 4 CAP
Phosphorus U- 3. mg/dL or 15% 6 AAB
Phosphorus 0.4 mg/dL or 15% 6 AAB
Phosphorus 12% 8 CFX
Phosphorus -urine
Analyte Fluid Method Limit Source
Phosphorus -urine U- 0.5 mg/dL or 12% 2 WLSH
Phosphorus, urine
Analyte Fluid Method Limit Source
Phosphorus, urine U- AU640 23% 4 CAP
Plasma Renin Activity
Analyte Fluid Method Limit Source
Plasma Renin Activity 1.0 ng/mL/hr, 25% 7 RCPA
Plasma Total Porphyrin
Analyte Fluid Method Limit Source
Plasma Total Porphyrin 3 nmol/L, 15% 7 RCPA
Platelet count
Analyte Fluid Method Limit Source
Platelet count +/- 25% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Platelet, count
Analyte Fluid Method Limit Source
Platelet, count B- 13.4% 5 BV
Platelets
Analyte Fluid Method Limit Source
Platelets 25% 6 AAB
pO2
Analyte Fluid Method Limit Source
pO2 Radiometer 725 3 SD 4 CAP
pO2 3SD 6 AAB
pO2 5 mm Hg, 5% 7 RCPA
pO2 2 SD 8 CFX
Polylysine
Analyte Fluid Method Limit Source
Polylysine 45 mmol/L or 30% 6 AAB
Potassium
Analyte Fluid Method Limit Source
Potassium +/- 0.5 mmol/L 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Potassium Radiometer 725 0.5 mmol/L 4 CAP
Potassium S- 5.8% 5 BV
Potassium (B)Leuc- 16% 5 BV
Potassium 0.2 mmol/L 7 RCPA
Potassium 6% 8 CFX
Potassium - urine
Analyte Fluid Method Limit Source
Potassium - urine U- 2 SD 2 WLSH
Potassium, concentration
Analyte Fluid Method Limit Source
Potassium, concentration U- 31.3% 5 BV
Potassium, output
Analyte Fluid Method Limit Source
Potassium, output U- 28.4% 5 BV
Potassium, urine
Analyte Fluid Method Limit Source
Potassium, urine U- AU640 29% 4 CAP
Potassium-POCT
Analyte Fluid Method Limit Source
Potassium-POCT POCT 2.0 mmol/L 7 RCPA
Potassium-Urine
Analyte Fluid Method Limit Source
Potassium-Urine U- 2.0 mmol/L, 10% 7 RCPA
Potassium`
Analyte Fluid Method Limit Source
Potassium` AU640 0.5 mmol/L 4 CAP
Pre-albumin
Analyte Fluid Method Limit Source
Pre-albumin 2.5 SD 2 WLSH
Prealbumin
Analyte Fluid Method Limit Source
Prealbumin BNII 25% or 5 mg/dL (greater) 4 CAP
Prealbumin S- 14.5% 5 BV
Pregnancy, Serum
Analyte Fluid Method Limit Source
Pregnancy, Serum pos/neg 6 AAB
Primidone
Analyte Fluid Method Limit Source
Primidone +/- 25% 1 CLIA, 2 WLSH, 6 AAB
Primidone +/- 15% 3 NYS
Primidone 15% 8 CFX
Procainamide
Analyte Fluid Method Limit Source
Procainamide +/- 15% 3 NYS
Procainamide Abbott AxSym 25% 4 CAP
Procainamide 25% 6 AAB
Procainamide 20% 8 CFX
Procainamide (and metabolite)
Analyte Fluid Method Limit Source
Procainamide (and metabolite) +/- 25% 1 CLIA, 2 WLSH, 6 AAB
Procainamide, N-Acetyl (NAPA)
Analyte Fluid Method Limit Source
Procainamide, N-Acetyl (NAPA) 25% 6 AAB
Procollagen type 1 N-terminal
Analyte Fluid Method Limit Source
Procollagen type 1 N-terminal S- 10.5% 5 BV
Progesterone
Analyte Fluid Method Limit Source
Progesterone 300 pg/mL or 30% 2 WLSH
Progesterone +/-25% or 1.0 ng/mL 3 NYS
Progesterone Centaur 3 SD 4 CAP
Progesterone 0.3 ng/mL or 30% 6 AAB
Progesterone 2 nmol/L, 25% 7 RCPA
Progesterone 2 SD 8 CFX
Prolactin
Analyte Fluid Method Limit Source
Prolactin 3.6 ng/mL or 30% 2 WLSH
Prolactin +/-25% or 1.0 ug/L 3 NYS
Prolactin Centaur 3 SD 4 CAP
Prolactin 3.6 ng/mL or 30% 6 AAB
Prolactin 20 mU/L, 20% 7 RCPA
Prolactin 2 SD 8 CFX
Prolactin (men)
Analyte Fluid Method Limit Source
Prolactin (men) S- 21.1% 5 BV
Prolyl endopeptidase
Analyte Fluid Method Limit Source
Prolyl endopeptidase P- 19.3% 5 BV
Propoxyphene
Analyte Fluid Method Limit Source
Propoxyphene Pos/Neg 2 WLSH
Propoxyphene 20% or 2 SD 3 NYS
Prostate-Specific Antigen
Analyte Fluid Method Limit Source
Prostate-Specific Antigen 0.9 ng/mL or 30% 6 AAB
Prostatic specific antigen (PSA)
Analyte Fluid Method Limit Source
Prostatic specific antigen (PSA) S- 30% 5 BV
Protein
Analyte Fluid Method Limit Source
Protein 10% 2 WLSH
Protein (Total)
Analyte Fluid Method Limit Source
Protein (Total) 5.0 g/L 7 RCPA
Protein - Total
Analyte Fluid Method Limit Source
Protein - Total 6% 8 CFX
Protein C
Analyte Fluid Method Limit Source
Protein C S- 18.7% 5 BV
Protein El. Interpr, Serum
Analyte Fluid Method Limit Source
Protein El. Interpr, Serum Sebia Hydrasis LS 90% consensus 4 CAP
Protein El. Interpr, Ur 24
Analyte Fluid Method Limit Source
Protein El. Interpr, Ur 24 Sebia Hydrasis LS 90% consensus 4 CAP
Protein El. Interpr, Urine
Analyte Fluid Method Limit Source
Protein El. Interpr, Urine Sebia Hydrasis LS 90% consensus 4 CAP
Protein S
Analyte Fluid Method Limit Source
Protein S P- 20.7% 5 BV
Protein, concentration
Analyte Fluid Method Limit Source
Protein, concentration U- 43.5% 5 BV
Protein, output
Analyte Fluid Method Limit Source
Protein, output U- 40% 5 BV
Protein, Total
Analyte Fluid Method Limit Source
Protein, Total AU640 10% 4 CAP
Protein, total
Analyte Fluid Method Limit Source
Protein, total S- 3.4% 5 BV
Protein, Urine (qual)
Analyte Fluid Method Limit Source
Protein, Urine (qual) 80% Agreement 3 NYS
Protein,total - urine
Analyte Fluid Method Limit Source
Protein,total - urine U- 10% 2 WLSH
Prothrombin time
Analyte Fluid Method Limit Source
Prothrombin time +/- 15% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Prothrombin time P- 5.3% 5 BV
Prothrombin Time (PT)
Analyte Fluid Method Limit Source
Prothrombin Time (PT) 15% 6 AAB
PSA
Analyte Fluid Method Limit Source
PSA 0.9 ng/mL or 30% 2 WLSH
PSA +/- 3 SD 3 NYS
PSA Abbott AxSym 3 SD 4 CAP
PSA - free
Analyte Fluid Method Limit Source
PSA - free 0.9 ng/mL or 30% 2 WLSH
PTH
Analyte Fluid Method Limit Source
PTH Centaur 3 SD 4 CAP
PTH 2.5 pmol/L, 25% 7 RCPA
Pyridinoline/creatinine, morning spot
Analyte Fluid Method Limit Source
Pyridinoline/creatinine, morning spot U- 12.1% 5 BV
Pyruvate
Analyte Fluid Method Limit Source
Pyruvate B- 17.5% 5 BV
Qualitative hCG
Analyte Fluid Method Limit Source
Qualitative hCG Positive or Negative 3 NYS
Quinidine
Analyte Fluid Method Limit Source
Quinidine +/- 25% 1 CLIA, 2 WLSH, 6 AAB
Quinidine +/- 15% 3 NYS
Quinidine Abbott AxSym 25% 4 CAP
Quinidine 2.0 umol/L, 10% 7 RCPA
Quinidine 25% 8 CFX
RBC Folate
Analyte Fluid Method Limit Source
RBC Folate 2.5 SD 2 WLSH
RBC Total Porphyrin
Analyte Fluid Method Limit Source
RBC Total Porphyrin 0.3 umol/L rc, 15% 7 RCPA
Red cell distribution wide
Analyte Fluid Method Limit Source
Red cell distribution wide B- 4.6% 5 BV
Reticulocyte Count
Analyte Fluid Method Limit Source
Reticulocyte Count 0.50% or 30% 6 AAB
Reticulocyte highly fluorescent, count
Analyte Fluid Method Limit Source
Reticulocyte highly fluorescent, count S- 24% 5 BV
Reticulocyte low fluorescent, count
Analyte Fluid Method Limit Source
Reticulocyte low fluorescent, count S- 2.6% 5 BV
Reticulocyte medium fluorescent, count
Analyte Fluid Method Limit Source
Reticulocyte medium fluorescent, count S- 19.6% 5 BV
Reticulocyte, count
Analyte Fluid Method Limit Source
Reticulocyte, count S- 16.8% 5 BV
Reticulocytes
Analyte Fluid Method Limit Source
Reticulocytes 3 SD 2 WLSH
Retinol
Analyte Fluid Method Limit Source
Retinol S- 18.1% 5 BV
Rheumatoid factor
Analyte Fluid Method Limit Source
Rheumatoid factor Target value +/- 2 dilution or (pos. or neg.) 1 CLIA
Rheumatoid factor S- 13.5% 5 BV
Rheumatoid Factor
Analyte Fluid Method Limit Source
Rheumatoid Factor Positive or Negative or +/- 2 dilutions 3 NYS
Rheumatoid Factor BNII 2 SD 4 CAP
Rubella
Analyte Fluid Method Limit Source
Rubella Target value +/- 2 dilution or (pos. or neg.) 1 CLIA
Salicylate
Analyte Fluid Method Limit Source
Salicylate 25% 2 WLSH
Salicylate +/- 15% 3 NYS
Salicylate 0.1 mmol/L, 10% 7 RCPA
Salicylates
Analyte Fluid Method Limit Source
Salicylates AU640 3 SD 4 CAP
Salicylates 25% 6 AAB
Salicylates 20% 8 CFX
SCC antigen
Analyte Fluid Method Limit Source
SCC antigen S- 45.8% 5 BV
Sedimentation Rate [ESR]
Analyte Fluid Method Limit Source
Sedimentation Rate [ESR] 2.5 SD 2 WLSH
Selenium
Analyte Fluid Method Limit Source
Selenium B- 14.5% 5 BV
Selenium P- 14.5% 5 BV
Serotonin
Analyte Fluid Method Limit Source
Serotonin 0.3 umol/day, 30% 7 RCPA
Sex hormone binding globulin (SHBG)
Analyte Fluid Method Limit Source
Sex hormone binding globulin (SHBG) S- 21.1% 5 BV
SHBG
Analyte Fluid Method Limit Source
SHBG 5 nmol/L, 10% 7 RCPA
Sickle Cell Screen
Analyte Fluid Method Limit Source
Sickle Cell Screen Pos/Neg 2 WLSH
Sodium
Analyte Fluid Method Limit Source
Sodium +/- 4 mmol/L 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Sodium Radiometer 725 4 mmol/L 4 CAP
Sodium AU640 4 mmol/L 4 CAP
Sodium S- 0.9% 5 BV
Sodium (B)Leuc- 57.7% 5 BV
Sodium (B)Erythr- 4.6% 5 BV
Sodium 3.0 mmol/L 7 RCPA
Sodium 4 mmol/L, 5% 8 CFX
Sodium - urine
Analyte Fluid Method Limit Source
Sodium - urine U- 2 SD 2 WLSH
Sodium, concentration
Analyte Fluid Method Limit Source
Sodium, concentration U- 28.8% 5 BV
Sodium, output
Analyte Fluid Method Limit Source
Sodium, output U- 32% 5 BV
Sodium, urine
Analyte Fluid Method Limit Source
Sodium, urine U- AU640 26% 4 CAP
Sodium-Sweat
Analyte Fluid Method Limit Source
Sodium-Sweat Sweat 2 mmol/L, 10% 7 RCPA
Sodium-Urine
Analyte Fluid Method Limit Source
Sodium-Urine U- 2.0 mmol/L, 10% 7 RCPA
Specific Gravity
Analyte Fluid Method Limit Source
Specific Gravity U- 0.01 6 AAB
Specific gravity, Urine (qual)
Analyte Fluid Method Limit Source
Specific gravity, Urine (qual) 80% Agreement 3 NYS
Sperm Count
Analyte Fluid Method Limit Source
Sperm Count 3 million/mL or 25% 6 AAB
Sperm Morphology
Analyte Fluid Method Limit Source
Sperm Morphology 5% normal or 20%% 6 AAB
Sperm Viability
Analyte Fluid Method Limit Source
Sperm Viability 5% viable or 20%% 6 AAB
Superoxide dismutase
Analyte Fluid Method Limit Source
Superoxide dismutase (B)Erythr- 13.5% 5 BV
Superoxide dismutase S- 19.1% 5 BV
Sweat Conductivity
Analyte Fluid Method Limit Source
Sweat Conductivity 2 mmol/L, 10% 7 RCPA
T Uptake
Analyte Fluid Method Limit Source
T Uptake 7% 8 CFX
T3 uptake
Analyte Fluid Method Limit Source
T3 uptake +/- 3 SD by method 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
T3 Uptake
Analyte Fluid Method Limit Source
T3 Uptake Centaur 3 SD 4 CAP
T3, T3
Analyte Fluid Method Limit Source
T3, T3 Centaur 3 SD 4 CAP
T3-uptake
Analyte Fluid Method Limit Source
T3-uptake S- 5.3% 5 BV
T4, Free
Analyte Fluid Method Limit Source
T4, Free Centaur 3 SD 4 CAP
T4, Total
Analyte Fluid Method Limit Source
T4, Total Centaur 20% or 1 ug/dL (greater) 4 CAP
Tacrolimus (FK 506)
Analyte Fluid Method Limit Source
Tacrolimus (FK 506) IMX 3 SD 4 CAP
Testosterone
Analyte Fluid Method Limit Source
Testosterone 0.3 ng/mL or 30% 2 WLSH
Testosterone +/-25% or 1.0 ng/dL 3 NYS
Testosterone Centaur 3 SD 4 CAP
Testosterone Saliva- 22.7% 5 BV
Testosterone S- 14% 5 BV
Testosterone 0.3 ng/mL or 30% 6 AAB
Testosterone 0.5 nmol/L, 20% 7 RCPA
Testosterone 2 SD 8 CFX
Testosterone,free
Analyte Fluid Method Limit Source
Testosterone,free 0.3 ng/mL or 30% 2 WLSH
THC-cannabinoids
Analyte Fluid Method Limit Source
THC-cannabinoids 20% or 2 SD 3 NYS
Theophylline
Analyte Fluid Method Limit Source
Theophylline +/- 25% 1 CLIA, 2 WLSH, 6 AAB
Theophylline +/- 15% 3 NYS
Theophylline Abbott AxSym 25% 4 CAP
Theophylline 3.0 umol/L, 10% 7 RCPA
Theophylline 25% 8 CFX
Thyroglobulin
Analyte Fluid Method Limit Source
Thyroglobulin S- 17.8% 5 BV
Thyroid stimulating hormone
Analyte Fluid Method Limit Source
Thyroid stimulating hormone +/- 3 SD 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Thyroid Stimulating Hormone
Analyte Fluid Method Limit Source
Thyroid Stimulating Hormone 3SD 6 AAB
Thyroid Stimulating Hormone 30% 8 CFX
Thyroid stimulating hormone (TSH)
Analyte Fluid Method Limit Source
Thyroid stimulating hormone (TSH) S- 24.6% 5 BV
Thyroxin binding globulin (TBG)
Analyte Fluid Method Limit Source
Thyroxin binding globulin (TBG) S- 7.1% 5 BV
Thyroxine
Analyte Fluid Method Limit Source
Thyroxine +/- 20% or 1.0 mcg/dL (greater) 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Thyroxine 8 nmol/L, 15% 7 RCPA
Thyroxine (T4)
Analyte Fluid Method Limit Source
Thyroxine (T4) S- 8.3% 5 BV
Thyroxine - Free
Analyte Fluid Method Limit Source
Thyroxine - Free 2 SD 8 CFX
Thyroxine - Total
Analyte Fluid Method Limit Source
Thyroxine - Total 8% 8 CFX
Thyroxine, Free
Analyte Fluid Method Limit Source
Thyroxine, Free 3SD 6 AAB
Thyroxine, Total
Analyte Fluid Method Limit Source
Thyroxine, Total 1.0 µg/dL or 20% 6 AAB
TIBC
Analyte Fluid Method Limit Source
TIBC Centaur 20% 4 CAP
TIBC 10.0 umol/L 7 RCPA
Tissue polypeptide antigen (TPA)
Analyte Fluid Method Limit Source
Tissue polypeptide antigen (TPA) S- 36.1% 5 BV
Tissue polypeptide specific antigen (TPS
Analyte Fluid Method Limit Source
Tissue polypeptide specific antigen (TPS S- 58.3% 5 BV
Tobramycin
Analyte Fluid Method Limit Source
Tobramycin +/- 25% 1 CLIA, 2 WLSH, 6 AAB
Tobramycin +/- 15% 3 NYS
Tobramycin Abbott AxSym 25% 4 CAP
Tobramycin 0.5 mg/L, 10% 7 RCPA
Tobramycin 25% 8 CFX
Total Beta hCG
Analyte Fluid Method Limit Source
Total Beta hCG +/- 3 SD 3 NYS
Total Bilirubin, Neonatal
Analyte Fluid Method Limit Source
Total Bilirubin, Neonatal 15 umol/L, 10% 7 RCPA
Total Carotenoids
Analyte Fluid Method Limit Source
Total Carotenoids 0.4 umol/L, 10% 7 RCPA
Total catecolamines, concentration, 24h
Analyte Fluid Method Limit Source
Total catecolamines, concentration, 24h U- 29.8% 5 BV
Total Estriol
Analyte Fluid Method Limit Source
Total Estriol +/-25% or 3.0 ng/mL 3 NYS
Total Glycated Hemoglobin
Analyte Fluid Method Limit Source
Total Glycated Hemoglobin 1.2 or 20% 2 WLSH
Total Iron Binding Capacity (TIBC)
Analyte Fluid Method Limit Source
Total Iron Binding Capacity (TIBC) 25% 6 AAB
Total protein
Analyte Fluid Method Limit Source
Total protein +/- 10% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Total Protein
Analyte Fluid Method Limit Source
Total Protein U- 1.0 mg/dL or 25% 6 AAB
Total Protein 10% 6 AAB
Total protein, urine
Analyte Fluid Method Limit Source
Total protein, urine U- AU640 44% 4 CAP
Total Protein-CSF
Analyte Fluid Method Limit Source
Total Protein-CSF CSF 0.1 g/L, 10% 7 RCPA
Total Protein-Urine
Analyte Fluid Method Limit Source
Total Protein-Urine U- 0.1 g/L, 10% 7 RCPA
Total PSA
Analyte Fluid Method Limit Source
Total PSA 1.5 ug/L, 15% 7 RCPA
Total T3 (Endocrinology)
Analyte Fluid Method Limit Source
Total T3 (Endocrinology) 0.3 nmol/L, 20% 7 RCPA
Total T3 (General Chemistry)
Analyte Fluid Method Limit Source
Total T3 (General Chemistry) 0.3 nmol/L, 15% 7 RCPA
Total T4
Analyte Fluid Method Limit Source
Total T4 8 nmol/L, 15% 7 RCPA
Transferrin
Analyte Fluid Method Limit Source
Transferrin 2.5 SD 2 WLSH
Transferrin BNII 20% 4 CAP
Transferrin S- 3.8% 5 BV
Transferrin 0.5 g/L 7 RCPA
Transferrin 12% 8 CFX
Tricyclic Antidepressants
Analyte Fluid Method Limit Source
Tricyclic Antidepressants Pos/Neg 2 WLSH
Tricyclic Antidepressants 20% or 2 SD 3 NYS
Tricyclic Antidepressants 10 nmol/L, 10% 7 RCPA
Tricyclic Antidepressants 15% 8 CFX
Triglyceride
Analyte Fluid Method Limit Source
Triglyceride S- 27.9% 5 BV
Triglyceride 0.20 mmol/L, 10% 7 RCPA
Triglycerides
Analyte Fluid Method Limit Source
Triglycerides +/- 25% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Triglycerides AU640 25% 4 CAP
Triglycerides 15% 8 CFX
Triiodothyronine
Analyte Fluid Method Limit Source
Triiodothyronine +/- 3 SD 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Triiodothyronine (T3)
Analyte Fluid Method Limit Source
Triiodothyronine (T3) S- 11.4% 5 BV
Triiodothyronine - Free
Analyte Fluid Method Limit Source
Triiodothyronine - Free 20% 8 CFX
Triiodothyronine - Total
Analyte Fluid Method Limit Source
Triiodothyronine - Total 20% 8 CFX
Triiodothyronine, Free (Free T3)
Analyte Fluid Method Limit Source
Triiodothyronine, Free (Free T3) 1.5 pg/mL or 30% 6 AAB
Triiodothyronine, Total (T3)
Analyte Fluid Method Limit Source
Triiodothyronine, Total (T3) 3SD 6 AAB
Troponin I
Analyte Fluid Method Limit Source
Troponin I Centaur not evaluated 4 CAP
Troponin I 0.9 ng/mL or 30% 6 AAB
Troponin I 0.2 ng/mL, 10% 7 RCPA
Troponin I 2 SD 8 CFX
Troponin I - qualitative
Analyte Fluid Method Limit Source
Troponin I - qualitative Pos/Neg 2 WLSH
Troponin I - quantitative
Analyte Fluid Method Limit Source
Troponin I - quantitative 2 SD 2 WLSH
Troponin T
Analyte Fluid Method Limit Source
Troponin T 0.1 ng/mL or 30% 6 AAB
Troponin T 0.1 ng/mL, 10% 7 RCPA
Troponin T 2 SD 8 CFX
Troponin T - qualitative
Analyte Fluid Method Limit Source
Troponin T - qualitative Pos/Neg 2 WLSH
Troponin T - quantitative
Analyte Fluid Method Limit Source
Troponin T - quantitative 2 SD 2 WLSH
TSH
Analyte Fluid Method Limit Source
TSH Centaur 3 SD 4 CAP
TSH 0.6 mU/L, 15% 7 RCPA
Tumor Necrosis Factor-a
Analyte Fluid Method Limit Source
Tumor Necrosis Factor-a S- 48.4% 5 BV
TUptake
Analyte Fluid Method Limit Source
TUptake 3SD 6 AAB
uE3 (Maternal Sera)
Analyte Fluid Method Limit Source
uE3 (Maternal Sera) +/- 3 SD 3 NYS
Unsaturated Iron Binding Capacity (UIBC)
Analyte Fluid Method Limit Source
Unsaturated Iron Binding Capacity (UIBC) 25% 6 AAB
Urate
Analyte Fluid Method Limit Source
Urate S- 11.9% 5 BV
Urate 0.050 mmol/L 7 RCPA
Urate, concentration, 24h
Analyte Fluid Method Limit Source
Urate, concentration, 24h U- 28.7% 5 BV
Urate, output, 24h
Analyte Fluid Method Limit Source
Urate, output, 24h U- 21.1% 5 BV
Urate-Urine
Analyte Fluid Method Limit Source
Urate-Urine U- 0.3 mmol/L 7 RCPA
Urea
Analyte Fluid Method Limit Source
Urea AU640 9% or 2 mg N/dL (greater) 4 CAP
Urea S- 15.7% 5 BV
Urea 0.1 mmol/L, 10% 7 RCPA
Urea Nitrogen
Analyte Fluid Method Limit Source
Urea Nitrogen +/- 2 mg/dL or +/- 9% (greater) 1 CLIA
Urea Nitrogen - urine
Analyte Fluid Method Limit Source
Urea Nitrogen - urine U- 2 mg/dL or 9% 2 WLSH
Urea, concentration, 24h
Analyte Fluid Method Limit Source
Urea, concentration, 24h U- 27.3% 5 BV
Urea, output, 24h
Analyte Fluid Method Limit Source
Urea, output, 24h U- 22.1% 5 BV
Urea, urine
Analyte Fluid Method Limit Source
Urea, urine U- AU640 21% 4 CAP
Urea-POCT
Analyte Fluid Method Limit Source
Urea-POCT POCT 1.0 mmol/L, 10% 7 RCPA
Urea-Urine
Analyte Fluid Method Limit Source
Urea-Urine U- 20 mmol/L, 10% 7 RCPA
Urea/Urea Nitrogen
Analyte Fluid Method Limit Source
Urea/Urea Nitrogen 16% 8 CFX
Uric acid
Analyte Fluid Method Limit Source
Uric acid +/- 17% 1 CLIA, 2 WLSH, 3 NYS, 6 AAB
Uric Acid
Analyte Fluid Method Limit Source
Uric Acid AU640 17% 4 CAP
Uric Acid U- 17% 6 AAB
Uric Acid 17% 6 AAB
Uric Acid 12% 8 CFX
Uric Acid - urine
Analyte Fluid Method Limit Source
Uric Acid - urine U- 17% 2 WLSH
Uric acid, urine
Analyte Fluid Method Limit Source
Uric acid, urine U- AU640 24% 4 CAP
Urine ALA
Analyte Fluid Method Limit Source
Urine ALA 5 umol/L, 25% 7 RCPA
Urine Creatinine
Analyte Fluid Method Limit Source
Urine Creatinine U- 3 mg/dL or 15% 6 AAB
Urine Microalbumin
Analyte Fluid Method Limit Source
Urine Microalbumin U- 10 mg/L or 25% 6 AAB
Urine Porphobilinogen (Quantitative)
Analyte Fluid Method Limit Source
Urine Porphobilinogen (Quantitative) 5 umol/L, 20% 7 RCPA
Urine Total Porphyrin
Analyte Fluid Method Limit Source
Urine Total Porphyrin 15 nmol/L, 15% 7 RCPA
Valproate
Analyte Fluid Method Limit Source
Valproate 25 umol/L, 10% 7 RCPA
Valproic acid
Analyte Fluid Method Limit Source
Valproic acid +/- 25% 1 CLIA, 2 WLSH, 6 AAB
Valproic acid +/- 15% 3 NYS
Valproic Acid
Analyte Fluid Method Limit Source
Valproic Acid Abbott AxSym 25% 4 CAP
Valproic Acid 25% 6 AAB
Valproic Acid 15% 8 CFX
Valproic Acid, free
Analyte Fluid Method Limit Source
Valproic Acid, free TDX 3 SD 4 CAP
Vancomycin
Analyte Fluid Method Limit Source
Vancomycin 25% 2 WLSH
Vancomycin +/- 15% 3 NYS
Vancomycin Abbott AxSym 3 SD 4 CAP
Vancomycin 1.5 ug/mL or 25% 6 AAB
Vancomycin 2.0 mg/L, 10% 7 RCPA
Vancomycin 20% 8 CFX
Vanilmandelic Acid concentration, 24h
Analyte Fluid Method Limit Source
Vanilmandelic Acid concentration, 24h U- 31.3% 5 BV
Vitamin A
Analyte Fluid Method Limit Source
Vitamin A 0.3 umol/L, 10% 7 RCPA
Vitamin B-12
Analyte Fluid Method Limit Source
Vitamin B-12 Centaur 3 SD 4 CAP
Vitamin B12
Analyte Fluid Method Limit Source
Vitamin B12 60 pg/mL or 30% 2 WLSH
Vitamin B12 +/- 25% 3 NYS
Vitamin B12 60 pg/mL or 30% 6 AAB
Vitamin B12 20 pmol/L, 20% 7 RCPA
Vitamin D3
Analyte Fluid Method Limit Source
Vitamin D3 5 nmol/L, 15 7 RCPA
Vitamin E
Analyte Fluid Method Limit Source
Vitamin E 5.0 umol/L, 10% 7 RCPA
Von Willebrand factor
Analyte Fluid Method Limit Source
Von Willebrand factor P- 7.4% 5 BV
Water
Analyte Fluid Method Limit Source
Water S- 3.3% 5 BV
White cell differentiation
Analyte Fluid Method Limit Source
White cell differentiation Target +/- 3 SD based on percentage of different types of white cells 1 CLIA, 2 WLSH
Whole Blood Glucose
Analyte Fluid Method Limit Source
Whole Blood Glucose 6 mg/dL or 10% 6 AAB
Whole Blood Prothrombin Time
Analyte Fluid Method Limit Source
Whole Blood Prothrombin Time 15% 6 AAB
Zinc
Analyte Fluid Method Limit Source
Zinc P- 11% 5 BV
Zinc S- 13.5% 5 BV
ZPP:
Analyte Fluid Method Limit Source
ZPP: +/-15% (µmol/mol heme) 3 NYS

Abbreviations and Sources

Abbreviation Source
1 CLIA CLIA '88, CLIA
2 WLSH Wisconsin State Laboratory of Hygiene
3 NYS Wadsworth Center of the New York State Department of Health
4 CAP College of American Pathologists (CAP)
5 BV 2004 update of the Spanish Society of Clinical Chemistry and Molecular Pathology (SEQC) table of Desirable Quality Specifications based on Biological Variation.
6 AAB American Association of Bioanalysts (AAB)
7 RCPA The Royal College of Pathologists of Australasia and the Australasian Clinical Biochemist association Quality Assurance Program
8 CFX Canadian Fixed limits from the College of Physicians and Surgeons of Saskatchewan

Ready to learn more?     Contact Us